Medical Research Articles Published in December 2012

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
12/17/2012
Bispecific Fynomer-antibody fusion proteins targeting two epitopes on HER2 Cancer Research
12/17/2012
Population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of various covariates Cancer Research
12/17/2012
The prognosis of T1a, T1b N0 M0, HER2+ patients in Korea. Cancer Research
12/17/2012
Long-term survival of patients with HER2 metastatic breast cancer treated by targeted therapies. Cancer Research
12/17/2012
A Phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC) Cancer Research
12/17/2012
Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer. Cancer Research
12/17/2012
The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years later Cancer Research
12/17/2012
Lapatinib versus trastuzumab, or both, added to preoperative chemotherapy for breast cancer: A meta-analysis of randomized evidence Cancer Research
12/17/2012
Impact of compliance with National Comprehensive Cancer Network guidelines on adjuvant trastuzumab administration for patients with HER2-positive breast cancer. Cancer Research
12/17/2012
A Multicenter Phase 2 Study (JO22997) Evaluating the Efficacy and Safety of Trastuzumab Emtansine in Japanese Patients With Heavily Pretreated HER2-Positive Metastatic Breast Cancer Cancer Research
12/17/2012
Molecular effects of lapatinib in HER2 positive ductal carcinoma in situ (DCIS) Cancer Research
12/17/2012
Cardiac monitoring during adjuvant trastuzumab therapy for breast cancer Cancer Research
12/17/2012
Inhibiting telomerase to reverse trastuzumab (T) resistance in HER2+ breast cancer Cancer Research
12/17/2012
Comparison of treatment patterns and outcomes in metastatic breast cancer patients initiated on trastuzumab vs. lapatinib; a retrospective analysis Cancer Research
12/17/2012
Pharmacokinetics and exposure-efficacy relationship of trastuzumab emtansine in EMILIA, a phase 3 study of trastuzumab emtansine vs capecitabine and lapatinib in HER2-positive locally advanced or metastatic breast cancer Cancer Research
12/17/2012
Chemotherapy can enhance trastuzumab-mediated ADCC Cancer Research
12/17/2012
A Phase I Study of MM-302, a HER2-targeted Liposomal Doxorubicin, in Patients with Advanced, HER@- Positive Breast Cancer Cancer Research
12/17/2012
Identification of ErbB2 function in the heart: implication for anti-ErbB2 therapy in breast cancer Cancer Research
12/17/2012
Completed SN33 Trial: 60 month follow-up of Early Stage Node Positive HER2 Negative patients with NeuVax ™(E75) and sargramostim. Cancer Research
12/17/2012
Trastuzumab emtansine in HER2-positive metastatic breast cancer: pooled safety analysis from seven studies Cancer Research
12/17/2012
Interim Results from a Phase 1b/2a Study of Trastuzumab Emtansine and Docetaxel, With and Without Pertuzumab, in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Cancer Research
12/17/2012
Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer Cancer Research
12/17/2012
Clinicopathological features among patients with HER2-positive breast cancer with prolonged response to trastuzumab based therapy Cancer Research
12/17/2012
Selective Crossover in Randomized Trials of Adjuvant Trastuzumab for Breast Cancer: Coping with Success Cancer Research
12/17/2012
Pertuzumab (P) in combination with trastuzumab (T) and docetaxel (D) in elderly patients with HER2-positive metastatic breast cancer in the CLEOPATRA study Cancer Research
12/17/2012
Influence of bevacizumab on local-regional recurrence in triple negative breast cancer Cancer Research
12/17/2012
The deficient eNOS c.894G>T genotype is not associated with increased severity of hypertension and proteinuria in breast cancer patients receiving bevacizumab Cancer Research
12/17/2012
Sorafenib plus Ixabepilone as First-Line Treatment for Patients with HER2-Negative Metastatic Breast Cancer: Preliminary Results of the Phase II Trial of the Sarah Cannon Research Institute Cancer Research
12/17/2012
Management of Antiangiogenics' Renovascular Safety in breast cancer. Subgroup and intermediate results of the MARS Study. Cancer Research
12/17/2012
Quality of life (QoL) results from the TURANDOT trial comparing two bevacizumab (BEV)-containing regimens as first-line treatment for HER2-negative metastatic breast cancer (mBC) Cancer Research
12/17/2012
Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - a randomized phase II study. Cancer Research
12/17/2012
Bevacizumab (B) in the adjuvant treatment of breast cancer - first toxicity results from Eastern Cooperative Oncology Group trial E5103. Cancer Research
12/17/2012
A phase 2 randomized trial of docetaxel (DOC) alone or in combination with therapeutic cancer vaccine, CEA-, MUC-1-TRICOM (PANVAC) Cancer Research
12/17/2012
The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients Cancer Research
12/17/2012
A phase I study of a DNA plasmid based vaccine encoding the HER-2/neu intracellular domain in subjects with HER2+ breast cancer. Cancer Research
12/17/2012
Phase II study of autologous dendritic cell vaccination in patients with HER2 negative breast cancer combined with neoadjuvant chemotherapy Cancer Research
12/17/2012
Final Results of the Phase I/II Trials of the E75 Adjuvant Breast Cancer Vaccine Cancer Research
12/17/2012
Survival advantage in patients with metastatic breast cancer receiving endocrine therapy plus Sialyl Tn-KLH vaccine: post hoc analysis of a large randomized trial Cancer Research
12/17/2012
Time savings with trastuzumab subcutaneous (SC) injection vs. trastuzumab intravenous (IV) infusion: First results from a Time-and-Motion study (T&M) Cancer Research
12/17/2012
Societal economics of the 21-gene Recurrence Score(R) in estrogen-receptor-positive early-stage breast cancer in Japan Cancer Research
12/17/2012
Budget impact analysis of everolimus for estrogen receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients in the United States Cancer Research
12/17/2012
CTX and CTX-related direct medication costs saved by testing biomarkers uPA and PAI-1 in primary breast cancer: Results of a prospective multi-center study at Certified Breast Centers in Germany Cancer Research
12/17/2012
Cost-effectiveness of 'radioguided occult lesion localization' (ROLL) versus 'wire-guided localization' (WGL) in breast conserving surgery for non-palpable breast cancer: results from a randomized controlled multicentre trial Cancer Research
12/17/2012
The benefit of targeted therapeutics in medical oncology since the development of trastuzumab Cancer Research
12/17/2012
Cost-effectiveness of gene expression profiling for ductal carcinoma in-situ (Oncotype DCIS Score) Cancer Research
12/17/2012
Analysis of test-therapy concordance for biomarkers uPA and PAI-1 in primary breast cancer in clinical hospital routine: Results of a prospective multi-center study at Certified Breast Cancers in Germany Cancer Research
12/17/2012
Compliance with radiation therapy in breast cancer patients in Southeastern Kentucky Cancer Research
12/17/2012
Alleviate the pain in the system: Using process improvement and systems design tools to strive for a high quality breast healthcare system in the District of Columbia metro area. Cancer Research
12/17/2012
Breast cancer screening and follow-up of abnormal mammogram results: A population-based study comparing results from an urban university cancer center to a national database. Cancer Research
12/17/2012
Women's responses to changes in US Preventive Services Task Force mammography screening guidelines: results from focus groups among ethnically diverse women Cancer Research
12/17/2012
Accrual of underrepresented minority women to breast cancer clinical trials in Inland Empire, California. Cancer Research
12/17/2012
Breast cancer risk assessment for underserved minority women in primary care: patient and provider perspectives Cancer Research
12/17/2012
Decision making from multidisciplinary team meetings to bedside: factors predicting for physicians' and breast cancer patients' acceptance of clinical trials proposed by MTMs Cancer Research
12/17/2012
Does empowering patients improve accrual to breast cancer trials? Cancer Research
12/17/2012
Developing the ePromotora: Increasing Promotora's Access to Breast Cancer Electronic Resources Cancer Research
12/17/2012
Tangled in the Breast Cancer Web: An Evaluation of the Usage of Web-based Information Resources by Breast Cancer Patients Cancer Research
12/17/2012
ARE WEB-BASED RESOURCES THE BREAST?: AN EVALUATION OF THE QUALITY OF ONLINE RESOURCES FOR BREAST CANCER PATIENTS Cancer Research
12/17/2012
Breast Cancer Radiation Therapy and the Risk of Developing Bronchiolitis Obliterans Organizing Pneumonia (BOOP): Communication of BOOP Risk by Breast Cancer Information Websites and General Medical Information Websites Cancer Research
12/17/2012
Extending breast conservation choices for women with breast cancer Cancer Research
12/17/2012
Radiotherapy-induced miR expression influences the formation of local recurrence in breast cancer Cancer Research
12/17/2012
miRNAs as novel therapeutic adjuvants for the prognosis and treatment of triple negative breast cancers Cancer Research
12/17/2012
Genetic variants located in beta2 adrenergic receptor gene (ADRB2) and miRNA let-7 binding site alter breast cancer susceptibility: a case control analysis Cancer Research
12/17/2012
Pre-surgical plasma microRNA pattern defines a biologically distinct triple negative breast cancer (TNBC) occuring in black (B) compared to white (W) women. Cancer Research
12/17/2012
Differences in microRNA expression patterns in breast cancer and triple negative tumors. Cancer Research
12/17/2012
Clinical significance of microRNA expression as a prognostic factor in early N+ breast cancer (BC) Cancer Research
12/17/2012
Prediction of Trastuzumab treatment response for HER2-positive breast cancer by microRNA profiling Cancer Research
12/17/2012
Hyperactive MAPK signaling alters expression of miR-221/222 and miR-30 families, which impacts multiple pathways and contributes to breast cancer aggressiveness and progression Cancer Research
12/17/2012
Luminal A breast cancer: identification of novel circulating miRNA biomarkers Cancer Research
12/17/2012
A functional role for miR-150 in breast cancer Cancer Research
12/17/2012
Novel Mechanisms of Metformin Action in TN Breast Cancer: Upregulation of miRNA 141 and 192, are Associated with a Decrease in Targets GRB2 and MSN Involved in Signaling and Motility Respectively Cancer Research
12/17/2012
Metformin mediated upregulation of microRNA-193 triggers apoptosis by decreasing fatty acid synthase Cancer Research
12/17/2012
OncomiR-569 deregulate p53 pathway and initiate breast oncogenesis Cancer Research
12/17/2012
High serum levels of miR-19a are associated with poor outcome in metastatic inflammatory breast cancer Cancer Research
12/17/2012
MicroRNAs -181 and -135a modulate tumour infiltrating immune cell programs in distinct molecular breast cancer subtypes Cancer Research
12/17/2012
Evaluation of BCL2 sequence variant in Iranian women patients with Breast cancer Cancer Research
12/17/2012
Investigating the role of BRCA1 in sensitivity to GRN163L, a telomerase template antagonist Cancer Research
12/17/2012
Triple negative receptor status is associated with low DNA repair capacity in women with breast cancer Cancer Research
12/17/2012
Insulin-like growth factor binding protein-3 is a key component of the breast cancer cell response to DNA-damaging therapy Cancer Research
12/17/2012
Aurora kinase regulates PKC-mediated MMP-9 expression and invasion in MCF-7 breast cancer cells Cancer Research
12/17/2012
Gallotannins and Gallic acid From Mango Fruit (Mangifera Indica L) Suppress Breast Cancer Tumor Growth by Targeting Phosphatidylinositol3-kinase (PI3K)-Akt-NF-kB Pathway and Associated microRNAs Cancer Research
12/17/2012
Analysis of a novel synergistic relationship between the FK506 binding protein FKBP52 and beta catenin in androgen receptor signaling pathways Cancer Research
12/17/2012
Defining the mechanism of breast cancer growth by chemokine receptor CXCR7 and Epidermal Growth Factor Receptor coupling interaction. Cancer Research
12/17/2012
The Role of Breast Tumor Kinase (Brk) in Cell Cycle Control Cancer Research
12/17/2012
Active pak6 induces aneuploidy in breast cancer cells. Cancer Research
12/17/2012
Spatio-temporal computational modeling of the p53-Mdm2 pathway Cancer Research
12/17/2012
Computational modeling of breast cancer growth and spread: the role of matrix degrading enzymes Cancer Research
12/17/2012
Intraductal delivery of RNAi-based therapeutics to gene targets identified through computational systems modeling Cancer Research
12/17/2012
The 5p12 breast cancer susceptibility locus is associated with MRPS30 expression in estrogen receptor - positive tumors Cancer Research
12/17/2012
The role of cellular heterogeneity on the therapeutic response of breast cancer: Clinical insights from a hybrid multiscale computational model Cancer Research
12/17/2012
Catalogued phospho-sensing peptides identifying active, oncogenic kinase signatures Cancer Research
12/17/2012
Squamous Cell Carcinoma Antigen 1 (SCCA1) Upregulation Causes Epithelial to Mesenchymal Transition (EMT) and Promotes Mammary Tumorigenesis Cancer Research
12/17/2012
Identifying and characterizing human kinases for novel regulators of epithelial-mesenchymal transition in breast cancer cells Cancer Research
12/17/2012
Epithelial-mesenchymal transition phenotype in breast cancers is associated with clinicopathologic factors indicating aggressive biologic behavior and poor clinical outcome Cancer Research
12/17/2012
Soluble factors from activated immune cells induce epithelial mesenchymal transition in inflammatory breast cancer cells Cancer Research
12/17/2012
E-Cadherin is Required for In Vivo Growth of Inflammatory Breast Cancer: Importance of Mesenchymal-Epithelial Transition (MET) and Role of HIF1{alpha} Cancer Research
12/17/2012
Significance of PELP1/HDAC2/microRNA-200 regulatory network in EMT and metastasis of breast cancer Cancer Research
12/17/2012
Epithelial-mesenchymal transition is associated with in situ to invasive transition of basal-like breast cancer Cancer Research
12/17/2012
DYRK2 regulates breast cancer invasion via Snail/E-cadherin pathway Cancer Research
12/17/2012
Expression of epithelial-mesenchymal transition (EMT)-related markers in primary tumors and matched lymph node metastases in breast cancer patients Cancer Research
12/17/2012
Expression of ALDH1 in metastasizing axillary lymphnodes in breast cancer Cancer Research
12/17/2012
Detection of tumor initiating cells (TIC) among the peripherally circulating epithelial tumor cells from patients with breast cancer Cancer Research
12/17/2012
Targeting breast cancer stem cells using the autopahgy inhibitor N-Acetyl cysteine Cancer Research
12/17/2012
Possible role for cancer stem cells: results from a pilot neoadjuvant trial of HER-2 positive breast cancer patients treated with a combination of (Nab)-paclitaxel and lapatinib. Cancer Research
12/17/2012
HIF-1alpha knockout radiosensitizes select Inflammatory Breast Cancer cells through reduction of stem-like cancer cells Cancer Research
12/17/2012
Receptor Activator of Nuclear Factor Kappa B (RANK) as a potential therapeutic target in triple-negative breast cancer Cancer Research
12/17/2012
A fluorescence STAT3 reporter preferentially expressed in human breast cancer tumor-initiating cells Cancer Research
12/17/2012
Targeting Hedgehog pathway to reverse chemoresistance in breast cancer stem cells Cancer Research
12/17/2012
Bisphenol A and mammary stem cells: implications in breast cancer susceptibility Cancer Research
12/17/2012
Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway Cancer Research
12/17/2012
Effect of aging on the function and transformation of murine mammary stem cells Cancer Research
12/17/2012
Antitumor Activity and Cancer Stem Cells Effect of Cetuximab in Combination with Ixabepilone in Triple Negative Breast Cancers (TNBC) Cancer Research
12/17/2012
Targeting mRNA Translation to Enhance the Radiosensitivity of Inflammatory Breast Cancer Stem Cells Cancer Research
12/17/2012
Cancer stem cells predict engraftment and poor prognosis of primary breast tumors Cancer Research
12/17/2012
Large-scale genomic instability consistently identifies BRCA1/2 inactivation in breast cancers Cancer Research
12/17/2012
Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey Cancer Research
12/17/2012
Discrepancy between CT and FDG-PET/CT in the staging of patients with inflammatory breast cancer: Implications for radiation therapy treatment planning Cancer Research
12/17/2012
Value of ultrasonography appearance of breast mass in prediction of histologic type Cancer Research
12/17/2012
Anti-ER monoclonal antibody SP1 seems more sensitive in the identification of ER alpha positive breast cancer cases than anti-ER monoclonal antibody 1D5 Cancer Research
12/17/2012
Discrepancy between routine and expert pathologists in histological assessment of early stage non palpable breast cancer and its impact on loco regional and systemic treatment Cancer Research
12/17/2012
Flat Epithelial Atypia: Management and outcome in three Dutch teaching hospitals Cancer Research
12/17/2012
Over- and Undergrading of Breast Cancer on Core Biopsies in Comparison to Surgical Specimens Cancer Research
12/17/2012
'Same-day diagnosis' of women suspected of breast cancer: success rate and impact on diagnostic quality and patients' anxiety levels Cancer Research
12/17/2012
Clinical-pathological features and outcomes of Invasive lobular (ILC) vs Invasive ductal (IDC) breast cancer (BC): a mono-institutional series. Cancer Research
12/17/2012
Identification of Molecular Apocrine Triple Negative Breast Cancer Using a Novel 2-Gene Assay and Comparison with Androgen Receptor Protein Expression and Gene Expression Profiling by DASL Cancer Research
12/17/2012
Complex fibroadenoma is not an independent risk marker for breast cancer Cancer Research
12/17/2012
Fibroadenomatoid changes are more prevalent in middle-aged women and have a positive association with invasive breast cancer Cancer Research
12/17/2012
Towards the standardisation of outcome reporting in reconstructive breast surgery: Initial results of the BRAVO (Breast Reconstruction and Valid Outcome) Study-A multicentre consensus process to develop a core outcome set for reconstructive breast surgery Cancer Research
12/17/2012
Radiation therapy and expander-implant breast reconstruction: an analysis of timing and comparison of complications Cancer Research
12/17/2012
The effect of body mass index on breast reconstruction outcomes. Cancer Research
12/17/2012
Improvement of accuracy and consistency in delineating the breast lumpectomy cavity using surgical clips Cancer Research
12/17/2012
Salvage Radiotherapy and Cisplatin for Triple Negative Breast Cancer: A Multi-Centre Study Cancer Research
12/17/2012
Relationship between coverage of axillary lymph nodes, with tangential breast irradiation, and body mass index Cancer Research
12/17/2012
Outcomes of low- risk Ductal Carcinoma in situ in South East Asian women treated with breast conservation surgery. Cancer Research
12/17/2012
Impact of receptor status on prognosis among breast cancer patients with brain metastases treated with Cyberknife radiosurgery Cancer Research
12/17/2012
Positive sentinel lymph nodes (SLNs) without axillary dissection in breast cancer: the tangent fields of irradiation may not allow optimal coverage and dose distribution in level I and II of the axilla Cancer Research
12/17/2012
Dosimetric feasibility and acute toxicity in a prospective trial of ultra-short course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device Cancer Research
12/17/2012
INTRAOPERATIVE ELECTRON RADIOTHERAPY IN EARLY STAGE BREAST CANCER. A SINGLE-INSTITUTION EXPERIENCE Cancer Research
12/17/2012
Selective use of post-mastectomy radiation therapy in the neoadjuvant setting Cancer Research
12/17/2012
Radiotherapy to the Primary Tumor Is Associated with Improved Survival in Stage IV Breast Cancer Cancer Research
12/17/2012
Benefit from Postoperative Radiotherapy for N1 Breast Cancer Cancer Research
12/17/2012
Outcome of stage II/III breast cancer treated with neoadjuvant versus adjuvant radiotherapy in British Columbia. Cancer Research
12/17/2012
Patterns of failure after accelerated partial breast irradiation by consensus panel group: A pooled analysis of William Beaumont Hospital and the American Society of Breast Surgeons Trial data Cancer Research
12/17/2012
A survival benefit from locoregional radiotherapy for node-positive and CMF treated breast cancer is most significant in Luminal A tumors Cancer Research
12/17/2012
Accelerated hypofractionated whole breast radiotherapy for localized breast cancer: the effect of a boost on patient reported long-term cosmetic outcome Cancer Research
12/17/2012
Long-term outcome of breast cancer patients treated with radiofrequency ablation Cancer Research
12/17/2012
Impact of awake brest cancer surgery on postoperative lymphocyte responses Cancer Research
12/17/2012
Patterns of relapse following re-irradiation of the breast using partial breast brachytherapy (PBB) Cancer Research
12/17/2012
Timing of infectious complications following breast conserving therapy with catheter-based accelerated partial breast irradiation Cancer Research
12/17/2012
Second conservative treatment for ipsilateral breast tumor recurrence: GEC-ESTRO Breast WG study Cancer Research
12/17/2012
Phyllodes tumour of the breast: A retrospective analysis of 87 cases Cancer Research
12/17/2012
Therapeutic mammaplasty does not cause a delay in the delivery of chemotherapy in high risk breast cancer patients Cancer Research
12/17/2012
Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after mastectomy with axillary lymph node dissection for breast cancer: results of a phase 2 randomized study. Cancer Research
12/17/2012
Risk reducing mastectomy for women with high personal breast cancer risk Cancer Research
12/17/2012
Atypical Ductal Hyperplasia diagnosed on directional vacuum-assisted biopsy: is surgical excision mandatory? Cancer Research
12/17/2012
Feasibility of liposuction for treatment of arm lymphedema from breast cancer. Cancer Research
12/17/2012
Intraoperative ultrasound guidance for excision of non-palpable breast cancer Cancer Research
12/17/2012
Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life two years after breast cancer surgery Cancer Research
12/17/2012
Contralateral Prophylactic Mastectomy and Survival: Selection Bias or True Survival Benefit? Cancer Research
12/17/2012
Skin sparing mastectomy - thorough breast tissue removal leads to a low local recurrence rate of breast cancer Cancer Research
12/17/2012
Total skin-sparing mastectomy in BRCA mutation carriers Cancer Research
12/17/2012
Nipple-sparing mastectomy and intra-operative nipple biopsy: To freeze or not to freeze? Cancer Research
12/17/2012
National Trends and Indications for Nipple-Sparing Mastectomy: An Analysis Using the Surveillance, Epidemiology, and End Results (SEER) Database Cancer Research
12/17/2012
Incidence rate of nipple areolar complex ischemia after nipple sparing mastectomy. Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. Cancer Research
12/17/2012
Lung cancer after treatment of breast cancer:retrospective study from Curie Institut Cancer Research
12/17/2012
Risk Assessment and Personalized Decision Support: The University of California Athena Breast Health Network Cancer Research
12/17/2012
Identifying women at increased risk for breast cancer using the electronic health record in an integrated health system Cancer Research
12/17/2012
Prognostic factors in young breast cancer patients over time - a 40 year longitudinal analysis Cancer Research
12/17/2012
Do BRCA1 and BRCA2 mutation carriers have an earlier natural menopause than their non-carrier relatives: A study from the Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (kConFab). Cancer Research
12/17/2012
The effect of weight change on breast adipose and dense tissue Cancer Research
12/17/2012
Diabetes, Related Factors and Breast Cancer Risk Cancer Research
12/17/2012
Meta-analysis of epidemiological studies of Insulin Glargine and Breast Cancer Risk Cancer Research
12/17/2012
Association of Age, Obesity and Incident Breast Cancer Phenotypes Cancer Research
12/17/2012
The gap between perceptions of risk and actual risk for breast cancer. Cancer Research
12/17/2012
Estrogen and Avoidance of Invasive Breast Cancer, Coronary Heart Disease and All-cause Mortality. Public Health Impact of Estrogen Guidelines for Women entering Menopause. Cancer Research
12/17/2012
Hormone replacement therapy, is there an increased risk of in situ breast cancer ? data from a french cohort Cancer Research
12/17/2012
Comparing data quality of client intake forms by interview mode: results of a pilot study on the use of audio computer-assisted self-interview (ACASI) in the Avon Breast Health Outreach Program Cancer Research
12/17/2012
Racial Disparities in the Incidence of Dose-limiting Chemotherapy Induced Peripheral Neuropathy Cancer Research
12/17/2012
Diabetes Increases the Risk of Breast Cancer Cancer Research
12/17/2012
A mammographic density prediction model using environmental factors, endogenous hormones and growth factors in Japanese women Cancer Research
12/17/2012
Enrichment of aldosterone synthase (CYP11B2) gene C-allele carriers in women at high risk in the OncoVue(R) polyfactorial risk model Cancer Research
12/17/2012
Association of single-strand breaks (SSBs) in normal breast DNA with estimates of breast cancer risk Cancer Research
12/17/2012
Towards a risk prediction model for breast cancer that utilizes breast tissue risk features Cancer Research
12/17/2012
Serum 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: the Multiethnic Cohort Study Cancer Research
12/17/2012
A nomogram based on clinical, imaging and histological data to predict the risk of upgrades to malignancy at surgery in biopsy-diagnosed premalignant lesions of the breast Cancer Research
12/17/2012
Automatic referral to genetic counseling for identification of BRCA1/2 mutations: a pilot program at Norton Cancer Institute, Louisville, KY. Cancer Research
12/17/2012
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk Cancer Research
12/17/2012
A Structured Genetic Risk Evaluation and Testing Program in the Community Oncology Practice Increases Identification of Individuals at Risk for BRCA Mutations Cancer Research
12/17/2012
Single nucleotide polymorphism testing for breast cancer risk assessment: patient trust and willingness to pay Cancer Research
12/17/2012
Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients Cancer Research
12/17/2012
Rapid genetic counseling and testing in newly diagnosed breast cancer patients, findings from an RCT Cancer Research
12/17/2012
Targeted resequencing of BRCA1 and BRCA2 in inherited breast cancer Cancer Research
12/17/2012
Edgetic perturbation of BRCT-mediated interactions caused by the BRCA1 H1686Q sequence variant Cancer Research
12/17/2012
TIMP-4 - Prognostic Marker and Treatment Target for Triple-Negative Breast Cancers. Cancer Research
12/17/2012
Fatty Acid Synthase (FASN) expression in Triple-Negative Breast Cancer Cancer Research
12/17/2012
Prospective Analysis of Fatty Acid Synthase (FASN) in Breast Cancer Tissue of Early-Stage Breast Cancer Patients Cancer Research
12/17/2012
Circulating HER2 extracellular domain (ECD) levels are associated with progression-free survival in metastatic breast cancer patients Cancer Research
12/17/2012
HOXB9, a gene promoting tumor angiogenesis and proliferation, is significantly associated with poor clincal outcomes in ER-positive breast cancer patients Cancer Research
12/17/2012
ING1 Expression Measured by AQUA can be an Independent Prognostic Marker in Breast Cancer Cancer Research
12/17/2012
miR-187 is an independent prognostic factor in lymph node-positive breast cancer patients. Cancer Research
12/17/2012
Microarray anlyses of breast cancers identify CH25H, a cholesterol gene, as a potential marker and target for late metastatic reccurences. Cancer Research
12/17/2012
Gene expression profile that predict outcome of Tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. Cancer Research
12/17/2012
Comparative proteomic analysis identifies a 15-protein signature related to clinical outcome of triple negative breast cancer Cancer Research
12/17/2012
A robust signature of long-term clinical outcome in breast cancer Cancer Research
12/17/2012
Retrospective evaluation of precision of gene-expression-based signatures of prognosis and tumor biology in replicate surgical biospecimens from patients with breast cancer Cancer Research
12/17/2012
Systematic expression analysis of the genes related to drug-resistance in isogenic docetaxel- and adriamycin-resistance breast cancer cell lines. Cancer Research
12/17/2012
Targeting Thyroid Receptor b in Estrogen Receptor Negative Breast Cancer Cancer Research
12/17/2012
HOXC10, a homeobox protein overexpressed in breast cancer, modulates the response to chemotherapy treatment. Cancer Research
12/17/2012
Novel insight into the tumor "flare" phenomenon and lapatinib resistance Cancer Research
12/17/2012
Notch-dependent Regulation of Novel Genes Associated with Trastuzumab Resistance Cancer Research
12/17/2012
Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo. Cancer Research
12/17/2012
Abcc10 status affects proliferation, metastases and tumor sensitivity Cancer Research
12/17/2012
The impact of the heregulin-HER receptor signaling axis on response to HER tyrosine kinase inhibitors. Cancer Research
12/17/2012
Reactivation of oncogenic signaling through mTOR inhibitors-induced feedback adaptations. Cancer Research
12/17/2012
PI3K/mTOR inhibition overcomes in vitro and in vivo trastuzumab resistance independent of feedback activation of pAKT Cancer Research
12/17/2012
MEDI3379, an antibody against HER3, is active in HER2-driven human breast tumor models Cancer Research
12/17/2012
Methioninase cell-cycle synchronization potentiates chemotherapy for breast cancer Cancer Research
12/17/2012
Rapamycin and Dalotuzumab in combination inhibit parental and endocrine resistant breast cancer cells. Cancer Research
12/17/2012
Growth differentiation factor 15, a novel mediator of progression in HER2-positive breast cancer Cancer Research
12/17/2012
The Class I Selective PI3K Inhibitor GDC-0941 Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing the Rate of Apoptosis Cancer Research
12/17/2012
Astemizole and calcitriol: A novel targeted therapeutic strategy for breast cancer Cancer Research
12/17/2012
Targeting basal-like breast cancer through downstream effectors of oncogene cooperation Cancer Research
12/17/2012
Antitumor activity of the novel mithramycin analog EC8042 in triple negative breast cancer Cancer Research
12/17/2012
TGF-{beta}2, A Novel Target of CD44-Promoted Breast Cancer Invasion Cancer Research
12/17/2012
Mifepristone modifies the tumor microenvironment increasing the therapeutic efficiency of low doses of Doxorubicin liposomes or paclitaxel-albumin nanoparticles in a murine model of breast cancer. Cancer Research
12/17/2012
CD146-suppresses breast tumor invasion via a novel transcription target TIMPv Cancer Research
12/17/2012
Effects of Statin on triple-negative breast cancer (TNBC) with Ets-1 overexpression Cancer Research
12/17/2012
Monoclonal antibodies against nicastrin for the treatment of breast canmcer: in vitro and in vivo characterisation and function Cancer Research
12/17/2012
Expression of genes spanning a breast cancer susceptibility locus on 6q25.1 is modulated by epigenetic modification Cancer Research
12/17/2012
Epigenetic silencing of glutamine synthetase (Glul) defines glutamine depletion therapy Cancer Research
12/17/2012
Cell surface receptor CDCP1 as a potential marker of triple negative breast cancers progression Cancer Research
12/17/2012
Clinical utility of functional analysis of FGFR kinase family for selecting patients who may benefit from FGFR inhibitors Cancer Research
12/17/2012
Isoform specific antibodies against the fibroblast growth factor receptor 2 have predictive and therapeutic implications in the treatment of human breast cancers Cancer Research
12/17/2012
RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate chemosensitivity in breast cancer Cancer Research
12/17/2012
NF-{kappa}B Upregulates {beta}1-integrin via Increased Transcriptional Activity in Three-dimensional Culture: a Mechanism by which Malignant Breast Cells Acquire Radioresistance Cancer Research
12/17/2012
Gamma-secretase inhibitors suppress the activation of NF{kappa}B and the expression of TNF{alpha}, IL-6 and IL-8 in triple negative breast cancer cells Cancer Research
12/17/2012
Zinc Finger Nuclease Genome Engineering Reveal Multiple Functions of Secretory Leukocyte Peptidase Inhibitor in Regulating Pleuripotency of Cancer Stem Cells in Inflammatory Breast Cancer Cancer Research
12/17/2012
Identification of novel G-protein coupled receptor targets in HER2-positive breast cancer. Cancer Research
12/17/2012
JAK2/STAT3 activity in inflammatory breast cancer supports the investigation of JAK2 therapeutic targeting Cancer Research
12/17/2012
Oncolytic Herpes Simplex Virus Vector G47{Delta} Effectively Targets Breast Cancer Stem Cells Cancer Research
12/17/2012
A Potential non-viral vector to transfect dendritic cell and thereby MHC-Class I antigen presentation might be a potential use in carcinoma Cancer Research
12/17/2012
Tartrate-resistant Acid Phosphatase (TRAcP)-Expressed Tumor-Associated Macrophages Promote Breast Cancer Progression Cancer Research
12/17/2012
Young women's breast cancer is characterized by increased immune suppression through circulating myeloid derived supressor cells Cancer Research
12/17/2012
Listeria monocytogenes-based bivalent Lm-LLO immunotherapy for the treatment of HER2/neu positive and triple negative breast cancer and its impact on immunosuppression Cancer Research
12/17/2012
Immunohistochemical analysis of Cancer Testis antigens and Topoisomerase 2-alpha expression in triple negative breast carcinomas: a retrospective study Cancer Research
12/17/2012
Monocytic immature myeloid cells permit tumor immune evasion during postpartum involution Cancer Research
12/17/2012
Tumor-initiated peripheral myeloid cell expansion is reversed by radiation therapy Cancer Research
12/17/2012
Combination of intratumoral CpG with systemic anti-OX40 and anti-CTLA4 mAbs eradicates established triple negative breast tumors in mice Cancer Research
12/17/2012
diagnostic value and clinical significance of integrin {alpha}v{beta}3 in breast mass Cancer Research
12/17/2012
SUVmax of FDG-PET/CT is Associated with Chemotherapy Response Assay Test Results and Prognostic Factors in Breast Cancer Patients Cancer Research
12/17/2012
Sonographic-pathological correlation in contrast-enhanced ultrasonography in the diagnosis of breast cancers. Cancer Research
12/17/2012
A comparison of MRI, PET-CT, and ultrasonography for evaluation of tumor response to neoadjuvant chemo-therapy in patients with locally advanced breast cancer Cancer Research
12/17/2012
A new real-time image fusion technique, a coordinated sonography and MRI using magnetic position tracking system, improves the sonographic identification of enhancing lesions in breast MRI Cancer Research
12/17/2012
Angiogenic effect of bevacizumab and paclitaxel in metastatic breast cancer: evaluation by contrast-enhanced ultrasonography using Sonazoid(R) Cancer Research
12/17/2012
Non-invasive classification of microcalcifications by the use of X-ray phase contrast mammography as a novel tool in breast diagnostics Cancer Research
12/17/2012
The Clinical Trial of New Optical Mammography Cancer Research
12/17/2012
The potential use of Optical Coherence Tomography for intraoperative breast tumour margin width estimation Cancer Research
12/17/2012
Feasibility study of a new volume navigation system-guided breast biopsy method for incidental enhancing lesions detected by breast contrast-enhanced magnetic resonance imaging Cancer Research
12/17/2012
Automatic BI-RADS Diagnosis of Breast Lesions by CAD(computer-aid diagnosis) Cancer Research
12/17/2012
Differences in FGF1 and FGFR2 expression in BRCA1-associated, BRCA2-associated, and sporadic breast carcinomas Cancer Research
12/17/2012
Could c-myc amplification replace Cahan's criterias to discriminate secondary from primary angiosarcoma of the breast? Cancer Research
12/17/2012
Clinico-pathological features of low-grade triple negative early breast cancers. Cancer Research
12/17/2012
Discordant Estrogen and Progesterone Receptor Status in Breast Cancer Cancer Research
12/17/2012
Inter-observer concordance of Ki-67 labeling index in breast cancer: Japan Breast Cancer Research Group (JBCRG) Ki-67 Ring Study Cancer Research
12/17/2012
Predicting OncoDX Recurrence Scores with Immunohistochemical Markers Cancer Research
12/17/2012
Efficacy and safety of lipomodelling and adipose tissue derived degenerative stem cells(ADRC) for breast reconstruction - Medium term follow up Cancer Research
12/17/2012
Tissue Expander/Implant Breast Reconstruction with and without Postmastectomy Radiation: Predictive Factors for Complications Cancer Research
12/17/2012
Reconstructive Outcomes of Nipple-Sparing Mastectomy: A Five Year Experience Cancer Research
12/17/2012
The use of specialist nurse-led clinics in preparation for reconstructive breast surgery. Cancer Research
12/17/2012
Reconstructive breast surgery using an acellular dermal matrix: prospective outcomes of an observational, cohort study (POBRAD). Cancer Research
12/17/2012
BRECONDA: Development and acceptability of an interactive decisional support tool for women considering breast reconstruction Cancer Research
12/17/2012
An efficient resource to accelerate research into the cause and prevention of breast cancer: the Love/Avon Army of Women Cancer Research
12/17/2012
The Pilot Trial of Intermittent Exemestane Therapy for Metastatic Breast Cancer Cancer Research
12/17/2012
Evaluation of Aromatase Inhibitor failure and total healthcare expenditures among post-menopausal women with metastatic ER+/HER2- breast cancer in the US Cancer Research
12/17/2012
A phase II trial of low dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to an aromatase inhibitor. Cancer Research
12/17/2012
A phase II study of combined fulvestrant and RAD001 (everolimus) in metastatic estrogen receptor (ER) positive breast cancer after aromatase inhibitor (AI) failure. Cancer Research
12/17/2012
A Phase Ib Dose Escalation Trial of RO4929097 (a {gamma}-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer. Cancer Research
12/17/2012
"Ethinylestradiol" is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents Cancer Research
12/17/2012
Preclinical Evaluation of Enzalutamide in Breast Cancer Models Cancer Research
12/17/2012
Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors - a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007) Cancer Research
12/17/2012
Pharmacological impact of endoxifen in a laboratory simulation of tamoxifen therapy in postmenopausal breast cancer patients Cancer Research
12/17/2012
Comparison of Compliance to Anti Estrogen Therapy in Patients with Early Breast Cancer followed at Tertiary Centers versus Through Family Physicians and Primary Surgeons: A Practice Review Cancer Research
12/17/2012
Long-term follow-up data of the side effect profile of anastrozole compared with tamoxifen in Japanese women: findings from N-SAS BC03 trial. Cancer Research
12/17/2012
Effect of letrozole on bone and joints in collagen-induced arthritis in mice Cancer Research
12/17/2012
Superior efficacy of anastrozole to tamoxifen as adjuvant therapy for postmenopausal patients with hormone-responsive breast cancer. Efficacy results of long-term follow-up data from N-SAS BC 03 trial Cancer Research
12/17/2012
Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States Cancer Research
12/17/2012
Understanding the complex non face-to-face interventions delivered by the clinical nurse specialists in metastatic breast cancer. Cancer Research
12/17/2012
Efficacy and safety of scalp cooling (SC) treatment for alopecia prevention in women receiving chemotherapy (CTX) for breast cancer (BC). Cancer Research
12/17/2012
Psycho-spiritual therapy for improving the quality of life and spiritual well-being of women with breast cancer Cancer Research
12/17/2012
A randomized controlled trial of support group intervention after breast cancer treatment: Results on sick leave, health care utilization and health economy. Cancer Research
12/17/2012
Sorafenib for treatment of breast-cancer related lymphedema Cancer Research
12/17/2012
A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials Cancer Research
12/17/2012
Music Therapy Reduces Radiotherapy-Induced Fatigue in Patients with Breast or Gynecological Cancer: A Randomized Trial Cancer Research
12/17/2012
A pilot study evaluating the benefits and feasibility of an exercise program for breast cancer patients receiving adjuvant chemotherapy. Cancer Research
12/17/2012
Development of a web-based survey tool to assess change in breast cancer (BrCa) survivor knowledge after receipt of cancer treatment summary and survivorship care plan (SCP). Cancer Research
12/17/2012
Symptoms, Physical Impairments, and Function in Breast Cancer Patients with Negative Axillary Lymph Nodes Cancer Research
12/17/2012
Patient Reported Outcomes after Breast Cancer Surgery and Adjuvant Therapy from a German Breast Cancer Centre Cancer Research
12/17/2012
Weight Change and Risk of Incident Diabetes After Breast Cancer Cancer Research
12/17/2012
Feasibility of Enrollment Into a Survivorship Care Plan Study at Initial Diagnosis Cancer Research
12/17/2012
Endothelial progenitor cells as novel markers of anthracycline induced cardiac injury Cancer Research
12/17/2012
Mortality among offspring of women diagnosed with breast cancer; a population based study Cancer Research
12/17/2012
Randomized, single blind trial comparing limited and intensive survivorship interventions following adjuvant therapy in a multiethnic cohort of breast cancer survivors Cancer Research
12/17/2012
Perception and practice of reproductive specialists towards fertility preservation of young breast cancer patients Cancer Research
12/17/2012
Effects of chemotherapy on the ovary: What you didn't know Cancer Research
12/17/2012
The combination of immunohistochemistry for predicting TP53 mutation is useful prognostic marker in breast cancer. Cancer Research
12/17/2012
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer Cancer Research
12/17/2012
The prediction of invasion in ductal carcinoma in situ: developing prediction model and validation Cancer Research
12/17/2012
Does E-cadherin or N-cadherin or epithelial-mesenchymal transition have a probability of clinical implication of the prognostic marker in invasive ductal carcinoma? Cancer Research
12/17/2012
Prognostic factors uPA/PAI-1: measurement in core needle biopsies Cancer Research
12/17/2012
Analysis of biomarker expression and biological subtype in primary tumour, corresponding lymph node and distant metastasis with 5-year follow-up Cancer Research
12/17/2012
The grade of accompanying DCIS in IDC as important prognostic factor Cancer Research
12/17/2012
Development and validation of ClinicoMolecular Triad Classification (CMTC), a platform for breast cancer (BC) prognostic and predictive gene signature portfolios. Cancer Research
12/17/2012
Mitotic Component of Grade Can Distinguish Breast Cancer Patients at Greatest Risk of Local Relapse Cancer Research
12/17/2012
Sialyl LewisX and inflammatory mediators in breast cancer patients: biological correlations and prognostic value Cancer Research
12/17/2012
Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients Cancer Research
12/17/2012
Expression of lipid metabolism genes in contralateral unaffected breast associated with estrogen receptor status of breast cancer Cancer Research
12/17/2012
The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling - A Study in 1,854 Chemo-Naive Women with N0/N1 Primary Breast Cancer. Cancer Research
12/17/2012
No Discordant Receptor Status Results among 50 Paired Breast and Axillary Metastasis Core Biopsies when Pre-analytic Variation is Controlled. Cancer Research
12/17/2012
Association between circulating tumor cells and molecular breast cancer subtypes Cancer Research
12/17/2012
Prognostic value of relative change in tumor marker CA 27.29 in early stage breast cancer - The SUCCESS trial Cancer Research
12/17/2012
Phosphorylation of Steroid Receptor Coactivator 3 (SRC3) at Ser543 is a novel independent prognostic marker in breast cancer Cancer Research
12/17/2012
Prognostic value of estrogen receptor status in women with synchronous or metachronous breast cancers Cancer Research
12/17/2012
SET index predicts response to endocrine therapy rather than prognosis independently of other genomic signatures in a blinded validation study. Cancer Research
12/17/2012
Evaluation of Prognostic and Predictive Performance of Breast Cancer Index and Its Components in Hormonal Receptor-Positive Breast Cancer Patients: A TransATAC Study Cancer Research
12/17/2012
Triple Negative Breast Cancer: prognosis of triple-negative breast cancers and non-triple-negative breast cancers in a large registry of certified breast units Cancer Research
12/17/2012
How well predict the 2011 St Gallen early breast cancer surrogate phenotypes metastatic survival? Cancer Research
12/17/2012
Clinical implications of molecular heterogeneity in highly proliferative, ER-positive, HER2-negative breast cancer Cancer Research
12/17/2012
The incidence of false negative of HER2/Neu status in primary breast cancer in the era of standardized testing: a Canadian prospective study. Cancer Research
12/17/2012
Prospective comparison of Recurrence Score and different definitions of luminal subtypes by central pathology assessment of single markers in early breast cancer: results from the phase III WSG-planB Trial Cancer Research
12/17/2012
Stem cell marker aldehyde dehydrogenase 1 in stromal cells strongly correlates with prognosis in breast cancer Cancer Research
12/17/2012
The Mammostrat Test is an Effective Tool to Stratify Patient Samples Previously Characterized as Intermediate by the Oncotype Dx Test Cancer Research
12/17/2012
A cross-platform comparison of genomic signatures and OncotypeDx score to discover potential prognostic/predictive genes and pathways Cancer Research
12/17/2012
PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy Cancer Research
12/17/2012
The structure design and biological activities of inhibitory peptides, which block the interactions among polycomb repressive complex 2 Cancer Research
12/17/2012
Screening of significantly hypermethylated genes in breast cancer using MIRA-based microarray and identifying their expression levels Cancer Research
12/17/2012
DNA methylation landscapes in ER-negative breast cancer Cancer Research
12/17/2012
Identifying a landscape of DNA methylation-driven genes in breast cancer using MethylMix Cancer Research
12/17/2012
Epigenetic Regulation of histone variants - a role in hormone therapy resistant breast cancer? Cancer Research
12/17/2012
Reactivation of epigenetically silenced retinoic acid receptor-beta for therapy of breast cancer- from molecular mechanism to potential clinical applications Cancer Research
12/17/2012
HER2 gene status change after taxanes based chemotherapy: be a ware of miss-interpretation of polyploidization! Impact for patient management. Cancer Research
12/17/2012
Phosphatidylinositol-3-kinase mutations are common in lobular neoplasia Cancer Research
12/17/2012
The large scale structure of the HER-2/neu amplicon in breast cancer Cancer Research
12/17/2012
PIK3CA mutations associate with decreased Ki67 in early stage breast cancer (BC) and better outcomes in patients even among those with low Ki67 tumors. Cancer Research
12/17/2012
BRCA1 regulates RHAMM function in breast cancer Cancer Research
12/17/2012
Exome sequencing identifies somatic mutations in basal-like breast cancer before and after neoadjuvant chemotherapy Cancer Research
12/17/2012
Integrating multiple molecular profiles with pathways to learn sub-type specific interactions with PARADIGM Cancer Research
12/17/2012
Single-cell RNA sequencing of paclitaxol-treated breast cancer cell lines to find individual cell response Cancer Research
12/17/2012
Specific Transcriptional Response of Four Blockers of Estrogen Receptors on Estrogen-Modulated Genes in ZR-75-1 Breast Cancer Xenografts Cancer Research
12/17/2012
Genomic evolution from primary breast cancers to distant metastases Cancer Research
12/17/2012
Breast-to-breast metastasis can cause hormone-receptor positive/triple negative bilateral synchronous tumors Cancer Research
12/17/2012
Preferential Activation of BP1 and c-Myc in Breast Cancer of African American Women Compared with Caucasian American Women Cancer Research
12/17/2012
Validation and comparison of CS-IHC4 score with a nomogram based on Ki67 index, Adjuvant! Online, and St. Gallen risk stratification to predict recurrence in early Hormone Receptor (HR)-positive breast cancers Cancer Research
12/17/2012
Pathway-based analysis of breast cancer Cancer Research
12/17/2012
Correlation between cyclin D1, estrogen and progesterone receptors in invasive breast cancer after short-term treatment with tamoxifen or anastrozole Cancer Research
12/17/2012
Assessment of Notch Signaling Pathway Components as Biomarkers for Triple Negative Breast Cancer: Comparison of Triple Negative Breast Cancer Cell Lines and Human Breast Cancer Samples. Cancer Research
12/17/2012
Clinical significance of Lysil oxidase-like 2 (LOXL 2) in breast cancer Cancer Research
12/17/2012
Identification and validation of a miRNA signature associated with breast cancer progression Cancer Research
12/17/2012
Determination of HER2 amplification by dual-color in situ hybridization before and after neoadjuvant chemotherapy Cancer Research
12/17/2012
Comparison of hormone receptor and HER-2 expression in primary breast cancers and sentinel lymph node metastases Cancer Research
12/17/2012
Quantitative measurement of HER2 expression in breast cancers: comparison with "real world" HER2 testing in a multi-center Collaborative Biomarker Study (CBS) and correlation with clinicopathological features Cancer Research
12/17/2012
Differential potency of TORC1/C2 (INK/MLN-128) and pan-PI3K (GDC0941) inhibitors on breast cancer polysome composition and phosphoprotein response biomarkers Cancer Research
12/17/2012
Mouse double minute 2 nuclear expression as a prognostic marker in patients with breast cancer Cancer Research
12/17/2012
Targeted Expression of the Human Chaperone BAG3 to the Murine Mammary Gland Dysregulates Mammary Gland Development and Differentiation By Unrestricted Expansion of Luminal Cells Cancer Research
12/17/2012
Modeling orthotopic and metastatic progression of mammary tumors to evaluate the efficacy of TGF-{beta} inhibitors in a pre-clinical setting Cancer Research
12/17/2012
Prolonged targeted overexpression of Aurora-A in mammary epithelium promotes mammary adenocarcinoma with genomic instability Cancer Research
12/17/2012
Prolactin cooperates with loss of p53 to promote mammary tumorigenesis. Cancer Research
12/17/2012
A robust transgenic mouse model to study male breast cancer. Cancer Research
12/17/2012
Identification of cancer stem cells (CD44+CD24-/lo) in bone marrow as a prognostic factor in early breast cancer patients Cancer Research
12/17/2012
The Collagen Receptor Endo180: A Metastatic Plasma Marker In Breast Cancer Modulated By Bisphosphonate Treatment Cancer Research
12/17/2012
Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients in neoadjuvant setting Cancer Research
12/17/2012
Accurate identification of metastatic breast cancer using methylated gene markers in circulating free DNA in peripheral blood Cancer Research
12/17/2012
circulating tumor cells in breast cancer exhibit dynamic changes in epithelial and mesenchymal cell composition Cancer Research
12/17/2012
Detection and characterization of circulating and disseminated tumour cells in blood and bone marrow of breast cancer patients by two different biochemical methods Cancer Research
12/17/2012
Immunocytochemistry staining for estrogen and progesterone receptor in circulating tumor cells: Concordance between primary and metastatic tumors. Cancer Research
12/17/2012
Tumor cell emboli in the lung and transcriptional profiles of circulating tumor cells derived from different vascular compartments in patients with metastatic breast cancer. Cancer Research
12/17/2012
Different numbers and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes. Cancer Research
12/17/2012
Effect of first-line chemotherapy in the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with metastatic breast cancer. Cancer Research
12/17/2012
Association between Circulating Tumor Cells and Bone Turnover Markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (ZOMAR study) Cancer Research
12/17/2012
Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients Cancer Research
12/17/2012
Circulating Tumor Cells (CTC) may Express HER2/neu in Patients With Early HER2/neu Negative Breast Cancer - Results of the German SUCCESS C Trial Cancer Research
12/17/2012
Establishment and validation of circulating tumor cell-based prognostic nomograms in 497 first-line metastatic breast cancer patients Cancer Research
12/17/2012
Multi-Institutional Evaluation of Bioimpedance Spectroscopy (BIS) in the Early Detection of Breast Cancer Related Lymphedema Cancer Research
12/17/2012
Higher toxicity of docetaxel for obese women with early breast cancer: lean body mass is a significant predictor of chemotherapy dose intensity reduction Cancer Research
12/17/2012
Ixabepilone-associated peripheral neuropathy in metastatic breast cancer patients and its effects on the ultrastructure of neurons Cancer Research
12/17/2012
The impact of musculoskeletal toxicity on adherence to endocrine therapy in women with early stage breast cancer- observations in a non-trial setting Cancer Research
12/17/2012
The relationship of relative dose intensity and supportive care to febrile neutropenia rates in patients with early stage breast cancer receiving chemotherapy: a prospective cohort study of chemotherapy-associated toxicity Cancer Research
12/17/2012
Comparison of efficacy of primary prophylaxis with pegfilgrastim, filgrastrim and a biosimilar filgrastim in TAC regimen (docetaxel, doxorubicin and cyclophosphamide) Cancer Research
12/17/2012
Patterns of granulocyte colony stimulating factor (G-CSF) use in elderly breast cancer (BC) patients receiving myelosuppressive chemotherapy Cancer Research
12/17/2012
High antitumoral activity of neoadjuvant chemotherapy (NCT) with weekly paclitaxel + capecitabine and trastuzumab in patients with locally advanced HER2+ breast cancer (HER2+ LABC): Preliminary results. Cancer Research
12/17/2012
Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC) Cancer Research
12/17/2012
A phase 2, multi-center, open label study evaluating the efficacy and safety of GRN1005 alone or in combination with trastuzumab in patients with brain metastases from breast cancer Cancer Research
12/17/2012
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases. Cancer Research
12/17/2012
The impact of estrogen receptor status on treatment outcomes following gamma knife radiosurgery for brain metastases of primary breast cancer Cancer Research
12/17/2012
Serum biomarkers identification using quantitative proteomics in patients (pts) with untreated brain metastases from HER2-positive breast cancer receiving capecitabine (C) and lapatinib (L) (UNICANCER LANDsCAPE trial) Cancer Research
12/17/2012
Male breast cancer: Overall survival in a single institution. Cancer Research
12/17/2012
Treatment outcomes for early stage male breast cancer: a single centre retrospective case-control study Cancer Research
12/17/2012
Male breast cancer: A comparison between BRCA mutation carriers and non-carriers in Hong Kong, Southern China Cancer Research
12/17/2012
Matched-pair analysis of patients with male and female breast cancer Cancer Research
12/17/2012
STATUS OF ANAPLASTIC LYMPHOMA KINASE (ALK) GENE IN INFLAMMATORY BREAST CARCINOMA Cancer Research
12/17/2012
Peptide-based molecular targeting of inflammatory breast cancer. Cancer Research
12/17/2012
A new in vitro method of growing and studying inflammatory breast cancer emboli Cancer Research
12/17/2012
Lymph node status and survival in inflammatory breast cancer Cancer Research
12/17/2012
Response to neoadjuvant systemic therapy (NST) in inflammatory breast cancer (IBC) according to estrogen receptor (ER) and HER2 expression. Cancer Research
12/17/2012
Regulation of inflammatory breast cancer cell invasion through Akt1/PKB{alpha} phosphorylation of RhoC GTPase Cancer Research
12/17/2012
Bartonella henselae Infection Detected in Patients with Inflammatory Breast Cancer. Cancer Research
12/17/2012
Modulation of mRNA and miRNAs by the novel histone deacetylase inhibitor, CG-1521 disrupts cytokinesis in SUM149PT inflammatory breast cancer cells Cancer Research
12/17/2012
Epidemiological risk factors and normal breast tissue markers in inflammatory breast cancer Cancer Research
12/17/2012
The role of breast size in detection of breast cancer in asian women Cancer Research
12/17/2012
The associations between body mass index and breast cancer intrinsic subtypes in Japanese women Cancer Research
12/17/2012
Breast cancer subtype distribution among HapMap classified ethnic groups Cancer Research
12/17/2012
The HER2 -positive subtypes by stage and race/ethnicity Cancer Research
12/17/2012
Odds of the triple negative subtype and survival of stages 1-3 breast cancer: Variation by race/ethnicity Cancer Research
12/17/2012
Clinical and Pathological Characteristics of Breast Cancer in Women with Neurofibromatosis Type 1 Cancer Research
12/17/2012
Vitamin D status at breast cancer diagnosis: correlation with patient and tumor characteristics Cancer Research
12/17/2012
HER2 positive breast carcinomas: trend in evolution between 1998 and 2008 and relationship with clinico-pathological characteristics in a population based study. Cancer Research
12/17/2012
Triple Negative Breast Cancer and BRCA Status: Implications for Genetic Counseling Cancer Research
12/17/2012
Title: Copy number variation and risk of chemotherapy-related infection. Cancer Research
12/17/2012
Impact of CYP3A variation on estrone levels and breast cancer risk Cancer Research
12/17/2012
Urinary levels of prostaglandin E2 metabolite and postmenopausal breast cancer Cancer Research
12/17/2012
Common variants at 10p14 and 1p11.2 display heterogeneity in breast cancer associations by E-cadherin tumor tissue expression in two independent datasets Cancer Research
12/17/2012
The prospective risk of ovarian cancer in 1433 women in a breast cancer family history clinic: no increased risk in families testing negative for BRCA1 and BRCA2. Cancer Research
12/17/2012
Initial treatment and survival among elderly breast cancer patients in the United States by estrogen receptor status and cancer stage at diagnosis: an analysis of national registry data 2000-2009 Cancer Research
12/17/2012
Importance of socioeconomic status in relation to breast cancer risk and prognostic factors in Argentina. Cancer Research
12/17/2012
Risk Factors for Breast Cancer in Women Served in Odete Valadares Maternity, Belo Horizonte-MG Cancer Research
12/17/2012
Retrospective database review of outcomes in invasive lobular carcinoma and invasive ductal carcinoma of the breast Cancer Research
12/17/2012
Effect of lifestyle and single nucleotide polymorphisms on breast cancer risk: A case-control study in Japanese women Cancer Research
12/17/2012
Prevalence and effects of off-label use of chemotherapeutic agents in elderly breast cancer patients: estimates from Surveillance, Epidemiology and End Results-Medicare data Cancer Research
12/17/2012
Recent trends in the characteristics of patients with distant stage breast cancer in the United States Surveillance, Epidemiology and End Stage Disease (SEER) program Cancer Research
12/17/2012
Incidence and survival among breast cancer patients in the United States by race and stage diagnosis: an analysis of national registry data 2000-2009 Cancer Research
12/17/2012
Initial treatment and survival among elderly breast cancer patients with positive estrogen receptor status by progesterone receptor status and stage: an analysis of US national registry data 2000-2009 Cancer Research
12/17/2012
Bisphosphonate use after primary breast cancer and risk of contralateral breast cancer using pharmacy data Cancer Research
12/17/2012
Cigarette smoking and postmenopausal breast cancer risk: results from the NIH-AARP Diet and Health Study Cancer Research
12/17/2012
The impact of Carcinoma in situ of the breast and family history on risk of subsequent breast cancer events and mortality - a population based study from Sweden Cancer Research
12/17/2012
Time-trends in survival in young women with breast cancer in a SEER population-based study Cancer Research
12/17/2012
Endocrine insensitivity defines inheritance of breast cancer prognosis Cancer Research
12/17/2012
Topoisomerase 1 gene copy aberrations in 52 human breast cancer cell lines and association to gene expression Cancer Research
12/17/2012
Plasma (p) VEGF-A and VEGFR-2 biomarker (BM) results from the BEATRICE phase III trial of bevacizumab (BEV) in triple-negative early breast cancer (BC) Cancer Research
12/17/2012
Effect of trastuzumab-based therapy on serum activin A levels in metastatic breast cancer. Cancer Research
12/17/2012
Topoisomerase 1 gene copy aberration is a frequent finding in clinical breast cancer samples Cancer Research
12/17/2012
Etirinotecan pegol in patients with metastatic breast cancer (mBC): Modeling CA27.29 response and its correlation with tumor response Cancer Research
12/17/2012
Change of circulating tumor cells before and after neoadjuvant chemotherapy in patients with primary breast cancer Cancer Research
12/17/2012
Use of the MiCK drug-induced apoptosis assay improves clinical outcomes in recurrent breast cancer (BRCA) Cancer Research
12/17/2012
Dynamic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer Cancer Research
12/17/2012
Serum anti-p53 antibody titers predict pathological response to preoperative chemotherapy in women with HER2 positive or triple negative breast cancer. Cancer Research
12/17/2012
PTEN mRNA positivity using in situ measurements is associated with better outcome in Tamoxifen treated breast cancer patients. Cancer Research
12/17/2012
Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy Cancer Research
12/17/2012
Predicting response to neoadjuvant letrozole Cancer Research
12/17/2012
Mechanisms behind trastuzumab resistance as neoadjuvant therapy in HER2-positive operable breast cancer Cancer Research
12/17/2012
Unique Molecular Subtypes of Triple Negative Breast Carcinomas by Routine IHC: Implications for Treatment and Prognosis Cancer Research
12/17/2012
Is it possible to predict the efficacy of a combination of Panitumumab plus FEC 100 followed by docetaxel (T) for patients with triple negative breast cancer (TNBC)? Final biomarker results from a phase II neoadjuvant trial. Cancer Research
12/17/2012
Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer Cancer Research
12/17/2012
Increase of serum androgen and its metabolites in postmenopausal primary breast cancer patients with disease progression during neo-adjuvant exemestane treatment; JFMC 34-0601 TR Cancer Research
12/17/2012
Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant treatment including an anti-angiogenic agent Cancer Research
12/17/2012
Predictive biomarker of pathologic complete response to neoadjuvant chemotherapy in triple negative breast cancer Cancer Research
12/17/2012
Baseline CD4/CD8 tumor infiltrating lymphocytes (TIL) ratio predicts pathologic response to neoadjuvant chemotherapy (NC) in breast cancer Cancer Research
12/17/2012
Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple Negative Breast Cancer Cancer Research
12/17/2012
Expression of Phosphorylated Activating Transcription factor 2 (ATF2) is associated with sensitivity to endocrine therapy in breast cancer Cancer Research
12/17/2012
Response and long-term outcomes after neo-adjuvant chemotherapy: Pooled dataset of patients stratified by molecular subtyping using MammaPrint and BluePrint Cancer Research
12/17/2012
Test of association between Ki67 index of early breast cancer and local relapse after adjuvant hypofractionated radiotherapy. Cancer Research
12/17/2012
Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer Cancer Research
12/17/2012
Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary Cancer Research
12/17/2012
Expression of SPARC in human breast cancer and its predictive value in the GeparTrio neoadjuvant trial. Cancer Research
12/17/2012
Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial Cancer Research
12/17/2012
Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients Cancer Research
12/17/2012
Genetic polymorphisms from genome-wide association study associated with the metabolic and cell proliferation pathways affect the time to distant metastases of hormone receptor-positive and Her2-negative early breast cancer Cancer Research
12/17/2012
Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen Cancer Research
12/17/2012
The role of TGF-beta receptor type 3 in breast cancer progression Cancer Research
12/17/2012
Analysis of the expression of claudin-3, -4, -7 and E-cadherin in breast cancer: are they surrogates for the claudin-low subtype? Cancer Research
12/17/2012
Poor prognosis early breast cancer: pathological characteristics of the Unicancer-PACS08 trial including patients treated with docetaxel or ixabepilone in adjuvant setting Cancer Research
12/17/2012
Automated analysis of Her2 FISH using combined Immunofluorescence and FISH signals Cancer Research
12/17/2012
HER2 Expression and Gene copy analysis by Immunofluorescence and Fluorescence in situ Hybridization, on a Single formalin-fixed paraffin-embedded tissue section Cancer Research
12/17/2012
Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer Cancer Research
12/17/2012
Characterization of PIK3CA mutations in lobular breast cancer Cancer Research
12/17/2012
Pathological assessment of discordant cases for molecular (BluePrint and MammaPrint) versus clinical subtypes for breast cancer among 621 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial Cancer Research
12/17/2012
Molecular subtyping improves stratification of patients into diagnostically more meaningful risk groups Cancer Research
12/17/2012
BreastMark: An integrated approach to mining publically available Transcriptomic Datasets relating to Breast Cancer Outcome Cancer Research
12/17/2012
Systemic treatment decision making for patients with stage I and II, hormone receptor positive, her2/neu negative breast cancer Cancer Research
12/17/2012
Comparison between RNA-Seq and Affymetrix gene expression data Cancer Research
12/17/2012
Expression of hormone-responsive genes in benign breast tissue varies with menstrual cycle phase and menopausal status Cancer Research
12/17/2012
Comparison of breast tumors with HER2 amplification and polysomy 17 Cancer Research
12/17/2012
Higher gene expression of CSPG4 in the basal-like subtype of invasive breast cancer and its negative association with lymph node metastasis Cancer Research
12/17/2012
Kinomic and phospho-proteomic analysis of breast cancer stem-like cells Cancer Research
12/17/2012
Identification of a "BRCAness" signature in triple negative breast cancer by Comparative Genomic Hybridization Cancer Research
12/17/2012
A seven-gene profile predicting benefit of postmastectomy radiotherapy independently of nodal status in high risk breast cancer Cancer Research
12/17/2012
Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2- tumors Cancer Research
12/17/2012
Protein pathway activation mapping of the I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with triple negative tumors Cancer Research
12/17/2012
A tri-modality imaging assessment algorithm to evaluate neoadjuvant therapy response in patients with operable breast cancer Cancer Research
12/17/2012
The metastatic rate of IMLN, when IMLN metastasis is suspected with PET CT. Cancer Research
12/17/2012
3D mapping of total choline in human breast cancer using high-speed MR spectroscopic imaging at 3T: initial experience during neoadjuvant therapy Cancer Research
12/17/2012
INTEGRATED PROGRAM FOR BREAST CANCER CONTROL: PARTIAL PRESENTATION OF THE RESULTS OBTAINED INTHE FIRST 24MONTHS OF OPERATION Cancer Research
12/17/2012
ANALYSIS OF INFRASTRUCTURE FOR MAMMOGRAPHY SCREENING IN THE STATE OF GOIAS, BRAZIL, 2010 Cancer Research
12/17/2012
The Cost of Mammography Screening in the United States by Screening Policy Cancer Research
12/17/2012
Screening Magnetic Resonance Imaging (MRI) of the breast in women at increased lifetime risk for breast cancer: A retrospective single institution study. Cancer Research
12/17/2012
Implementation and uptake of a provincial, population-based, organized breast screening program for high risk women in Ontario: The Ontario breast screening program (OBSP) high risk program. Cancer Research
12/17/2012
Cost-effectiveness of screening with additional MRI for women with familial risk for breast cancer without a genetic predisposition Cancer Research
12/17/2012
Is repetition of the contralateral mammogram of patients referred from breast cancer screening for unilateral findings necessary? Cancer Research
12/17/2012
Rates of Cancer Detection and Abnormal Results among Clients Recruited for Mammography through Outreach and Education Supported by the Avon Breast Health Outreach Program Cancer Research
12/17/2012
Survival impact of early detection of recurrence after surgery in early breast cancer patients Cancer Research
12/17/2012
Subtypes of screen-detected invasive breast cancer and symptomatic invasive breast cancer and their impact on survival Cancer Research
12/17/2012
Screen detected HER2 positive breast cancer within the West of London Breast Screening population:Incidence, Management and Outcome Cancer Research
12/17/2012
Increased risk of breast cancer in women with false-positive screening test: can it be entirely explained by misclassification? Cancer Research
12/17/2012
Use of contrast-enhanced computed tomography in clinical staging of asymptomatic breast cancer patients to detect asymptomatic distant metastases. Cancer Research
12/17/2012
Mammographic Screening: Good Prognosis Tumor Biology in Screen-detected Breast Cancers Cancer Research
12/17/2012
Mammographic density and estrogen receptor {alpha} gene polymorphism in Javanese ethnic women Cancer Research
12/17/2012
ESTIMATED RISK OF RADIATION-INDUCED BREAST CANCER FROM MAMMOGRAPHIC SCREENING Cancer Research
12/17/2012
Ultrasound as single mode of imaging may miss significant pathology in symptomatic women aged 35-39 Cancer Research
12/17/2012
The Role of Mammographic Calcification in the Neo-adjuvant Therapy of Breast Cancer Imaging Evaluation Cancer Research
12/17/2012
Surgical management of mammographic microcalcification is improved by full field digital mammography (FFDM) Cancer Research
12/17/2012
Breast density profile in a prospective large breast cancer screening program in South Brazil. Cancer Research
12/17/2012
Correlation of Mammographic breast density and tumor characteristics in Korean breast cancer patients Cancer Research
12/17/2012
Insulin, Insulin-like Growth Factor-1 and cycling estrogen predict premenopausal mammographic density. Cancer Research
12/17/2012
Creation of a "state-of-the-art" breast cancer data and biobank in Argentina Cancer Research
12/17/2012
A web-based data management system for a multicenter international breast cancer oriented blood, tissue, and data biobank Cancer Research
12/17/2012
The efficacy of recruitment and retention strategies for research subjects in an early phase investigator-initiated breast cancer trial. Cancer Research
12/17/2012
Distance of breast cancer from the skin influence axillary nodal metastasis Cancer Research
12/17/2012
Molecular Breast Imaging: A multicenter clinical registry to compare breast-specific gamma imaging (BSGI) and breast MRI in the detection of breast carcinoma Cancer Research
12/17/2012
Molecular Breast Imaging: the sensitivity of breast-specific gamma imaging (BSGI) as a diagnostic adjunct to mammography and ultrasound in a triple assessment protocol Cancer Research
12/17/2012
Quantitative Characterization of 3D Vasculature Spatial Patterns Within Tumor Microenvironment of Breast Cancer Stem Cells Cancer Research
12/17/2012
Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy Cancer Research
12/17/2012
Molecular imaging with trastuzumab and pertuzumab of HER2-positive breast cancer in mice: a step towards personalized medicine Cancer Research
12/17/2012
A novel 64Cu-liposomal PET agent (MM-DX-929) predicts response to liposomal chemotherapeutics in preclinical breast cancer models Cancer Research
12/17/2012
Tissue oxyhemoglobin dynamics measured with functional optical imaging immediately after starting chemotherapy correlates with markers of cellular proliferation and inflammation in a rat breast tumor model. Cancer Research
12/17/2012
FDG PET/CT for early monitoring of response to neoadjuvant chemotherapy in breast cancer patients. Cancer Research
12/17/2012
Comparison of 18F-FDG PET-CT and 11C-MET PET-CT for assessment of response to neoadjuvant chemotherapy in locally advanced breast carcinoma. Cancer Research
12/17/2012
18F-FDG PET/CT for the assessment of locoregional lymph node involvement and radiotherapy indication in stage II-III breast cancer treated with neoadjuvant chemotherapy Cancer Research
12/17/2012
Ductolobular breast carcinoma and the role of preoperative magnetic resonance imaging Cancer Research
12/17/2012
Clinicopathological Factors that Predict the Accuracy of MRI in the Preoperative Setting. Cancer Research
12/17/2012
Impact of Preoperative MRI on the Surgical Treatment of Breast Cancer: A SEER-Medicare Analysis Cancer Research
12/17/2012
Can MRI predict the response to neoadjuvant chemotherapy in breast cancer accurately? Cancer Research
12/17/2012
Practice patterns of MRI utilization for breast cancer treatment within the University of California system as part of the Athena initiative Cancer Research
12/17/2012
Compliance with Recommended Follow-Up after MRI-guided Core Needle Biopsy of Suspicious Breast Lesions: A Retrospective Study Cancer Research
12/17/2012
Clinical Findings and Outcomes from MRI Staging of Breast Cancer in a Diverse Population Cancer Research
12/17/2012
High-resolution diffusion weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3 Tesla Cancer Research
12/17/2012
Screening breast magnetic resonance imaging (MRI) in early-stage breast cancer survivors Cancer Research
12/17/2012
Effect of bilateral salpingo-oophrectomy on breast MRI fibroglandular volume and background parenchymal enhancement for BRCA 1/2 mutation carriers. Cancer Research
12/17/2012
The Relationship of Breast Density in Mammography and Magnetic Resonance (MR) Imaging in a High Risk Population Cancer Research
12/17/2012
Evaluation of 3D T2-weighted Breast MRI Cancer Research
12/17/2012
Utility of Preoperative Routine MRI and PET/CT in Breast Cancer Staging vs. Surgical Staging Cancer Research
12/17/2012
MRI enhancement in stromal tissue surrounding breast tumors: Association with RFS following neoadjuvant chemotherapy Cancer Research
12/17/2012
quantitative DCE-MRI to predict the response of primary breast cancer to neoadjuvant therapy Cancer Research
12/17/2012
Association of DCE-MRI texture features with molecular phenotypes and neoadjuvant therapy response in breast cancer Cancer Research
12/17/2012
Integrating dynamic magnetic resonance imaging and gene expression profiling reveals novel therapeutic targets in locally advanced breast cancer. Cancer Research
12/17/2012
The Utility of Margin Index to Predict Residual DCIS Following Breast Conserving Surgery Cancer Research
12/17/2012
Recurrence in Patients Diagnosed with Ductal Carcinoma in Situ: Predictors and Prognostic Significance Cancer Research
12/17/2012
Symptomatic DCIS is a risk factor for invasion and should be managed accordingly Cancer Research
12/17/2012
Differences in pathological and biological factors between DCIS, DCIS with microinvasion (DCIS-MI) and DCIS with concomitant invasive ductal carcinoma (DCIS-IDC). Cancer Research
12/17/2012
Should patients with comedo ductal carcinoma in situ (DCIS) be managed as if they have locally invasive breast cancer? Cancer Research
12/17/2012
Molecular definition of the transition of ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC). Cancer Research
12/17/2012
Osteocytic Connexin 43 Hemichannels in Prevention of Bone Metastasis Cancer Research
12/17/2012
Evaluating efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal related events. TRIUMPH: A pragmatic multicentre trial. Cancer Research
12/17/2012
Skeletal related Events and Bone Metastasis Patients with Breast Cancer in Japan. A Retrospective Study Cancer Research
12/17/2012
Molecular factors associated with bone metastases in breast cancer patients Cancer Research
12/17/2012
Safety and Efficacy of Zoledronic Acid Beyond 24 Months in Breast Cancer Patients Cancer Research
12/17/2012
Prospective study of treatment pattern, effectiveness, and safety of zoledronic acid (ZOL) therapy beyond 24 months: subgroup analysis of patients (pts) with metastatic bone disease (MBD) from breast cancer (BC). Cancer Research
12/17/2012
Clinical outcome in patients with surgically resected brain metastases from breast cancer: prognostic considerations regarding molecular status and established prognostic classification systems. Cancer Research
12/17/2012
The risk of brain metastases according to expression of selected immunohistochemical markers in primary breast cancers Cancer Research
12/17/2012
Incidence, predictive factors and outcome of brain metastases (BM) in a single institution cohort of breast cancer patients. Cancer Research
12/17/2012
Voyagers and their aids: The role of interactions between tumor and endothelial cells in brain metastasis Cancer Research
12/17/2012
Clinical features and outcomes of leptomeningeal metastasis in patients with breast cancer: a single center experience Cancer Research
12/17/2012
Prospective neo-adjuvant registry trial linking MammaPrint, subtyping and treatment response: Neo-adjuvant Breast Registry - Symphony Trial (NBRST) Cancer Research
12/17/2012
MINT I: Multi-Institutional Neo-adjuvant Therapy, MammaPrint Project I Cancer Research
12/17/2012
PROMIS: Prospective Registry Of MammaPrint in breast cancer patients with an Intermediate recurrence Score Cancer Research
12/17/2012
A RANDOMIZED PHASE III TRIAL COMPARING NANOPARTICLE-BASED PACLITAXEL WITH SOLVENT-BASED PACLITAXEL AS PART OF NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH EARLY BREAST CANCER (GeparSepto) GBG 69 Cancer Research
12/17/2012
ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial. Cancer Research
12/17/2012
ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer Cancer Research
12/17/2012
Eribulin/Cyclophosphamide versus Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer: A Randomized Phase II Trial of the Sarah Cannon Research Institute Cancer Research
12/17/2012
Neoadjuvant bevacizumab with weekly nanoparticle albumin bound (nab)-paclitaxel plus carboplatin followed by doxorubicin plus cyclophosphamide (AC) for triple negative breast cancer. Cancer Research
12/17/2012
NeoEribulin: A Phase II, non-randomized, open-label, single-arm, multicenter, exploratory pharmacogenomic study of single agent eribulin as neoadjuvant treatment for operable Stage I-II HER2 non-overexpressing breast cancer. Cancer Research
12/17/2012
Neurotoxicity characterization phase II randomized study of nab-paclitaxel versus conventional paclitaxel as first-line therapy of metastatic HER2-negative breast cancer. An ONSOCUR Study Group. Cancer Research
12/17/2012
ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients. Cancer Research
12/17/2012
Silent risk? Cardiovascular risk factors in survivors of breast cancer treated with anthracyclines. Cancer Research
12/17/2012
ADAPT - Adjuvant Dynamic marker-Adjusted Personalized Therapy trial optimizing risk assessment and therapy response prediction in early breast cancer Cancer Research
12/17/2012
Eniluracil + 5-fluorouracil + leucovorin (EFL) vs. capecitabine phase 2 trial for metastatic breast cancer Cancer Research
12/17/2012
The PREDICT Study (Prospective, Randomized Early Detection and Intervention after Breast Cancer-Treatment, for women at risk of lymphedema) Cancer Research
12/17/2012
Influence of strength and endurance training on selected physical and psychological parameters and on immune system, metabolism and circulating tumor cells during adjuvant chemotherapy Cancer Research
12/17/2012
Phase II randomized study of combination immunotherapy with or without Polysaccharide Krestin (PSK(R)) concurrently with a HER2 ICD peptide-based vaccine and trastuzumab in patients with stage IV breast cancer Cancer Research
12/17/2012
A pilot study of single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer scheduled for mastectomy Cancer Research
12/17/2012
Tivozanib in combination with paclitaxel vs placebo with paclitaxel in patients with locally advanced or metastatic triple-negative breast cancer Cancer Research
12/17/2012
Phase II study of panitumumab, nab-paclitaxel, and carboplatin for patients with primary inflammatory breast cancer (IBC) without HER2 overexpression Cancer Research
12/17/2012
Phase III randomized study of the oral pan-PI3K inhibitor BKM120 with fulvestrant in postmenopausal women with HR+/HER2- locally advanced or metastatic breast cancer resistant to aromatase inhibitor - BELLE-2 Cancer Research
12/17/2012
Phase III randomized study of the oral pan-PI3K inhibitor BKM120 with fulvestrant in postmenopausal women with HR+/HER2- locally advanced or metastatic breast cancer, treated with aromatase inhibitor, and progressed on or after mTOR inhibitor-based treatment - BELLE-3 Cancer Research
12/17/2012
A randomized, phase 2 study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with temozolomide (TMZ) or in combination with carboplatin (C) and paclitaxel (P) versus placebo plus C/P in subjects with BRCA1 or BRACA2 mutation and metastatic breast cancer Cancer Research
12/17/2012
A phase II, non-randomized, multicenter, exploratory trial of single agent BKM120 in patients with triple-negative metastatic breast cancer. Cancer Research
12/17/2012
AVASTEM: a phase II randomized trial evaluating anti-cancer stem cell activity of pre-operative bevacizumab and chemotherapy in breast cancer Cancer Research
12/17/2012
A PILOT PHASE II STUDY TO EVALUATE THE IMPACT OF DENOSUMAB ON DISSEMINATED TUMOR CELLS (DTC) IN PATIENTS WITH EARLY STAGE BREAST CANCER (ESBC) Cancer Research
12/17/2012
Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase 3 clinical trial Cancer Research
12/17/2012
Phase Ib/II study of an oral PI3K/mTOR inhibitor plus letrozole compared with letrozole (L) in pre-operative setting in patients with Estrogen Receptor-positive, HER2-negative early breast cancer (BC): Phase Ib preliminary data. Cancer Research
12/17/2012
Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC) Cancer Research
12/17/2012
A prospective, randomised multi-centre phase II study evaluating the adjuvant, neoadjuvant or palliative treatment with tamoxifen +/- GnRH analogue versus aromatase inhibitor + GnRH analogue in male breast cancer patients (GBG-54 MALE) Cancer Research
12/17/2012
A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-negative breast cancer: SWOG/NSABP S1207. Cancer Research
12/17/2012
Dovitinib (TKI258) or placebo in combination with fulvestrant in postmenopausal, endocrine-resistant HER2-/HR+ breast cancer: a phase II study Cancer Research
12/17/2012
Prospective multicentre study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial. Cancer Research
12/17/2012
SOFT and TEXT: Trials of tamoxifen and exemestane with and without ovarian function suppression for premenopausal women with hormone receptor-positive early breast cancer Cancer Research
12/17/2012
Intraoperative assessment of tumor margins with a new optical imaging technology: A multi-center, randomized, blinded clinical trial Cancer Research
12/17/2012
The Z11 design for breast cancer patients undergoing a mastectomy Cancer Research
12/17/2012
Clinical node negative breast cancer patients undergoing breast conserving therapy: follow-up versus sentinel lymph node biopsy Cancer Research
12/17/2012
Feasibility of sentinel node detection after neoadjuvant chemotherapy for patient with proved axillary lymph node involvement: the French prospective multiinstitutional GANEA 2 ongoing trial Cancer Research
12/17/2012
SHARE. A French multiceter phase III trial comparing accelerated partial irradiation (APBI) versus standard or hypofractionated whole breast irradiation in low risk of local recurrence breast cancer Cancer Research
12/17/2012
NSABP B-43: A phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx) Cancer Research
12/17/2012
LUX-Breast 2: Phase II, open-label study of oral afatinib in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) who progressed on prior trastuzumab and/or lapatinib* Cancer Research
12/17/2012
LUX-Breast 1: Randomized, Phase III trial of afatinib (BIBW 2992) and vinorelbine vs. trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment* Cancer Research
12/17/2012
LUX-Breast 3: Randomized Phase II trial of afatinib (BIBW 2992) alone or with vinorelbine versus investigator's choice of treatment in patients (pts) with HER2-positive breast cancer (BC) with progressive brain metastases after trastuzumab and/or lapatinib-based therapy* Cancer Research
12/17/2012
Open-label, Phase II trial of afatinib, with or without vinorelbine, for the treatment of HER2-overexpressing inflammatory breast cancer (IBC)* Cancer Research
12/17/2012
Dual blockade with Afatinib and Trastuzumab as neooadjuvant treatment for patients with locally advanced or operable breast cancer receiving taxane-anthracycline containing chemotherapy (DAFNE)-GBG70 Cancer Research
12/17/2012
NSABP FB-7 Trial: A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Therapy Regimens with Weekly Paclitaxel and Neratinib or Trastuzumab or Neratinib and Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab in Women with Locally Advanced HER2-Positive Breast Cancer Cancer Research
12/17/2012
TBCRC 022: Phase II Trial of Neratinib for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases Cancer Research
12/17/2012
DETECT III - A multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer but with HER2-positive circulating tumorcells Cancer Research
12/17/2012
Opti-HER HEART: A prospective, multicenter, single-arm, phase II study to evaluate the safety of neoadjuvant liposomal doxorubicin plus paclitaxel, trastuzumab, and pertuzumab in patients with operable HER2-positive breast cancer. Cancer Research
12/17/2012
Clinical outcomes among ErbB2+ MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study). Cancer Research
12/17/2012
Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LTP112515) Cancer Research
12/17/2012
A phase III randomized study of Paclitaxel and Trastuzumab versus Paclitaxel, Trastuzumab and Lapatinib in first line treatment of HER2 positive metastatic breast cancer. Cancer Research
12/17/2012
A Phase I pharmacokinetics trial comparing PF-05280014 and trastuzumab in healthy volunteers (REFLECTIONS B327-01) Cancer Research
12/17/2012
ALTERNATIVE: safety and efficacy of lapatinib (L), trastuzumab (T), or both in combination with an aromatase inhibitor (AI) for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer Cancer Research
12/17/2012
PERSEPHONE: Duration of Trastuzumab with Chemotherapy in women with HER2 positive early breast cancer. Cancer Research
12/17/2012
A single-arm phase IIIb study of pertuzumab and trastuzumab with a taxane as first-line therapy for patients with HER2-positive advanced breast cancer (PERUSE) Cancer Research
12/17/2012
A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer Cancer Research
12/17/2012
CYP2D6 and adjuvant tamoxifen: Impact on outcome in pre- but not postmenopausal breast cancer patients Cancer Research
12/17/2012
Venlafaxine inhibits the CYP2D6 mediated metabolic activation of tamoxifen: Results of a prospective multicenter study: (NCT00667121) Cancer Research
12/17/2012
Patients carrying CYP2C8*3 are at increased risk of paclitaxel-induced neuropathy Cancer Research
12/17/2012
CXCL13 mRNA predicts Docetaxel benefit in Triple Negative tumors Cancer Research
12/17/2012
HLA-DQA1*02:01/DRB1*07:01 as a biomarker for lapatinib-induced hepatotoxicity: prospective confirmation in a large randomised clinical trial (TEACH, EGF105485) Cancer Research
12/17/2012
Predictive genomic markers to chemotherapy and adjuvant trastuzumab via whole genome expression DASL profiling in the N9831 adjuvant study Cancer Research
12/17/2012
Predictive value of a proliferation score (MS) in postmenopausal women with endocrine-responsive breast cancer: results from International Breast Cancer Study Group (IBCSG) Trial IX Cancer Research
12/17/2012
Metabolic syndrome and recurrence within the 21-gene recurrence score assay risk categories in lymph node negative breast cancer Cancer Research
12/17/2012
DNA Damage and Repair in Mammary Gland Development Cancer Research
12/17/2012
The Akt inhibitor MK-2206 is an effective radio-sensitizer of p53 deficient triple negative breast cancer (TNBC) cells. Cancer Research
12/17/2012
The potential role of TLK2 as a therapeutic target in breast cancer. Cancer Research
12/17/2012
Therapeutic potential of targeting ATM-PELP1-p53 axis in triple negative breast cancer Cancer Research
12/17/2012
Two phase I trials exploring different dosing schedules of carboplatin (C), paclitaxel (P), and the poly-ADP-ribose polymerase (PARP) inhibitor, veliparib (ABT-888) (V) with activity in triple negative breast cancer (TNBC) Cancer Research
12/17/2012
Single nucleotide polymorphism of XRCC1 which participates in DNA repair mechanism predicts clinical outcome in relapsed or metastatic breast cancer patients treated with S1 and oxaliplatin chemotherapy: Results from multicenter prospective study (TORCH_KCSG BR07-03) Cancer Research
12/17/2012
Homologous Recombination Deficiency (HRD) score predicts pathologic response following neoadjuvant platinum-based therapy in triple-negative and BRCA1/2 mutation-associated breast cancer (BC) Cancer Research
12/17/2012
Impact of BRCA1/2 Mutation Status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer. Cancer Research
12/17/2012
BRCA1 insufficiency is predictive of superior survival in patients with triple negative breast cancer treated with platinum based chemotherapy Cancer Research
12/17/2012
BRCA1 inactivation induces NF-{kappa}B in human breast cancer cells and in murine and human mammary glands Cancer Research
12/17/2012
Significant Clinical impact of recurrent BRCA1 and BRCA2 (BRCA) mutations in Mexico Cancer Research
12/17/2012
Spanning the Continuum to assess, serve and navigate Latinas with breast cancer: A Tale of Six Projects Cancer Research
12/17/2012
Factors which affect surgical management in an underinsured, county hospital population Cancer Research
12/17/2012
Barriers to Breast Reconstructive Surgery in an Underprivileged Community: Does Income Really Matter? Cancer Research
12/17/2012
Disparities in the Utilization of Reconstruction after Mastectomy: The California Teachers Study Cancer Research
12/17/2012
Utilization of Oncotype DX in an inner-city population: Race or Place? Cancer Research
12/17/2012
Overall survival results of a multicenter randomized phase II study in locally advanced breast cancer patients treated with or without celecoxib for HER2 negative tumor (Remagus 02 trial) Cancer Research
12/17/2012
Neoadjuvant Sunitinib (S) Administered with Weekly Paclitaxel (P)/Carboplatin(C) in Patients (Pts) with Locally Advanced Triple-Negative Breast Cancer (TNBC): Preliminary Results from a Phase I/II Trial of the Sarah Cannon Research Institute. Cancer Research
12/17/2012
Increased Pathologic Complete Response Rate and Reduced Tumour RNA Levels Upon Treatment of Locally Advanced Breast Cancer with Neoadjuvant Concurrent Chemotherapy and Radiation Cancer Research
12/17/2012
Response to neoadjuvant chemotherapy and prognosis of primary breast cancer according to intrinsic subtype Cancer Research
12/17/2012
Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER) Cancer Research
12/17/2012
Immunohistochemical classification of intrinsic subtypes as a predictive biomarker of pathological compelete response in breast cancer patients treated with preoperative chemotherapy. Cancer Research
12/17/2012
A prospective multicenter randomized phase II neo-adjuvant study of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) followed by docetaxel, cyclophosphamide and trastuzumab (TCH) versus TCH followed by FEC versus TCH alone, in patients (pts) with operable HER2 positive breast cancer: JBCRG-10 study Cancer Research
12/17/2012
Neoadjuvant chemotherapy and pathologic complete response in relation to the clinical response, results from a phase III study (INTENS) of the Dutch breast cancer trialists' group (BOOG). Cancer Research
12/17/2012
Significance of examining biomarkers of residual tumors after neoadjuvant chemotherapy using trastuzumab in combination with anthracycline and taxane in patients with primary HER2-positive breast cancer Cancer Research
12/17/2012
Overall survival results of a multicenter randomized phase II study in locally advanced breast cancer patients treated with or without neoadjuvant Trastuzumab for HER2 positive tumor (Remagus 02 trial) Cancer Research
12/17/2012
Preoperative docetaxel (T) with or without capecitabine (X) following epirubicin, 5-fluorouracil and cyclophosphamide (FEC) in patients with operable breast cancer (OOTR N003): Results of comparative study and predictive marker analysis Cancer Research
12/17/2012
Adding capecitabine and trastuzumab to neoadjuvant breast cancer chemotherapy - first survival analysis of the GBG/AGO intergroup-study GeparQuattro. Cancer Research
12/17/2012
[bold]The adjuvant PANTHER study - A randomized comparison between dose-dense and tailored epirubicin (E), cyclophosphamide (C) and docetaxel (D) vs. standard dose 5-fluorouracil (F), epirubicin (E), cyclophosphamide (C) and docetaxel - First report on q Cancer Research
12/17/2012
Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a phase 2, single-arm feasibility study Cancer Research
12/17/2012
Efficacy, toxicity and quality of life in older patients with early-stage breast cancer treated with oral Tegafur-uracil or classical CMF (cyclophosphamide, methotrexate, and fluorouracil): an exploratory analysis of National Surgical Adjuvant Study for Breast Cancer (N-SAS BC) 01 Trial Cancer Research
12/17/2012
A multicenter randomized study comparing the dose dense G-CSF-supported sequential administration of FEC followed by docetaxel versus paclitaxel as adjuvant chemotherapy in women with axillary lymph node positive breast cancer. Cancer Research
12/17/2012
Chemotherapy for Breast Cancer Causes Sustained Alteration In Number and Type of B Lymphocytes Cancer Research
12/17/2012
Association Between Delayed Initiation of Adjuvant Chemotherapy and Survival in Breast Cancer: A Single-institution Study and A Systematic Review and Meta-analysis Cancer Research
12/17/2012
Breast cancer survival advantage with oral bisphosphonates use Cancer Research
12/17/2012
The association between timing in adjuvant chemotherapy administration and overall survival for women with breast cancer within the National Comprehensive Cancer Network (NCCN) Cancer Research
12/17/2012
Optimal duration of adjuvant chemotherapy for high risk node negative breast cancer patients: 6-year results of the prospective randomized phase III trial PACS 05. Cancer Research
12/17/2012
A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis. Cancer Research
12/17/2012
Quality of Life in Patients with Locally Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes who Received Eribulin Mesylate or Capecitabine in a Phase III, Open-label, Randomized Study Cancer Research
12/17/2012
A Retrospective Analysis of nab-Paclitaxel as First-Line Therapy for Metastatic Breast Cancer Patients With Poor Prognostic Factors Cancer Research
12/17/2012
First-line chemotherapy with pegylated liposomal doxorubicin versus capecitabine in elderly patients with metastatic breast cancer: results of the phase III OMEGA study of the Dutch Breast Cancer Trialists' Group (BOOG) Cancer Research
12/17/2012
Carboplatin, nab-paclitaxel and bevacizumab as first-line treatment for metastatic breast cancer. Cancer Research
12/17/2012
Low-dose capecitabine monotherapy in HER-2 negative metastatic breast cancer: a retrospective study. Cancer Research
12/17/2012
Results of a phase 2, multicenter, single-arm study of eribulin mesylate as first-line therapy for locally recurrent or metastatic HER2-negative breast cancer Cancer Research
12/17/2012
Evaluation on efficacy and safety of capecitabine plus docetaxel versus docetaxel monotherapy in metastatic breast cancer patients pretreated with anthracycline: Results from a randomized phase III study (JO21095) Cancer Research
12/17/2012
Comparative Preventive Efficacy of Select Chinese Herbs in Breast Carcinoma Derived Isogenic Cells with Modulated Estrogen Receptor Functions Cancer Research
12/17/2012
Topical 4-OHT trial in women with DCIS of the breast: report of plasma and breast tissue concentration of tamoxifen metabolites Cancer Research
12/17/2012
Biological Effects of Green Tea Capsule Supplementation in Pre-surgery Breast Cancer Patients Cancer Research
12/17/2012
Down-regulation of trefoil protein 1(TFF1) in normal breast tissue of postmenopausal women at increased risk for breast cancer on exemestane Cancer Research
12/17/2012
Chemoprevention in patients with newly diagnosed breast cancers Cancer Research
12/17/2012
Pilot study of a 1-year intervention of high-dose vitamin D in women at high risk for breast cancer. Cancer Research
12/17/2012
Gene expression changes in methylnitrosourea (MNU)-induced ER+ mammary cancers following short-term treatment of rats with SERMs (Tamoxifen and Arzoxifene) Cancer Research
12/17/2012
Effects Of An Allosteric AKT Inhibitor (MK2206) Administered With Or Without The Aromatase Inhibitor Vorozole In An ER+ Rat Mammary Cancer Model: Preventive And Therapeutic Effects Cancer Research
12/17/2012
Mass Spectrometry Based Quantitative Analysis of the HER Family receptors in FFPE Breast Cancer Tissue Cancer Research
12/17/2012
Association between Bone Turnover Markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (ZOMAR study) Cancer Research
12/17/2012
V Array: A novel tool for constructing virtual tissue microarrays (TMAs), an evaluation of its use in optimizing TMA construction for Ductal Carcinoma in Situ (DCIS). Cancer Research
12/17/2012
Liver derived epithelial cells as source of false positive circulating tumor cells in early breast cancer Cancer Research
12/17/2012
Revisiting chromosome 17q copy number aberrations in early high-risk breast cancer Cancer Research
12/17/2012
Enabling biomarker validation in breast cancer molecular subtypes: sensitivity and specificity of array-based subtype classification in 983 patients Cancer Research
12/17/2012
Prognostic relevance of statistically standardized estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in tamoxifen(TAM)-treated NCIC CTG MA.14 patients Cancer Research
12/17/2012
Using Natural Language Processing to Identify and Extract HER2 Value from a large EMR system Cancer Research
12/17/2012
Characterization of progesterone receptor biomarker for predicting antiprogestin activity in human cancers. Cancer Research
12/17/2012
Comparison of three commercial ER/PR assays on a single clinical outcome series. Cancer Research
12/17/2012
Estrogen receptor positivity: 10% or 1%? Cancer Research
12/17/2012
Effect of sample preservation method and transportation duration on tumor gene expression profiling in breast cancer. Cancer Research
12/17/2012
Inflammatory gene expression variations in the interval between core needle biopsy and excisional biopsy in early breast cancer Cancer Research
12/17/2012
Effect of biospecimen variables on proteomic biomarker assessment in breast cancer Cancer Research
12/17/2012
Evaluation of tissue processing factors affecting HER2 IHC staining intensity in breast cancer cell lines Cancer Research
12/17/2012
Comparison of HER2 expression by immunohistochemistry (IHC) using automated imaging system and fluorescence in situ hybridization (FISH). A retrospective analysis of 2853 cases Cancer Research
12/17/2012
Quantification of HER2 expression at the single cell level and HER2 intratumoral heterogeneity of breast cancer tissue samples using automated image analysis Cancer Research
12/17/2012
New high-quality HER2 IQFISH pharmDx™ assay with a 1/2 working day procedure and high concordance to HER2 FISH pharmDx™ Cancer Research
12/17/2012
Attainment of extremely high concordance rates between fluorescence in situ hybridization and immunohistochemistry in testing for human epidermal growth factor receptor 2 (HER2) in breast cancer using a normalized scoring system for immunohistochemistry: a four year experience with over 9000 cases Cancer Research
12/17/2012
Microvessel density as determined by computerized image analysis of CD34 and CD105 expression correlates with poor outcome in triple-negative breast cancer Cancer Research
12/17/2012
A newly angiogenic biomarker Vasohibin-1 expression in ductal carcinoma in situ of the breast. Cancer Research
12/17/2012
Upregulation of metabolism as a potential resistance mechanism to bevacizumab in primary breast cancer Cancer Research
12/17/2012
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Cancer Research
12/17/2012
Blockade of mTORC1 decreases CXCR4-mediated migration and metastasis Cancer Research
12/17/2012
The role of epsin in promoting Epithelial-Mesenchymal Transition and metastasis by activating NF-kB signaling in breast cancer Cancer Research
12/17/2012
Modeling Cancer Recurrence and the Therapeutic Effect of Adjuvant Systemic Therapy Cancer Research
12/17/2012
S100A7/RAGE axis enhances breast cancer growth by activating Stat3 signaling Cancer Research
12/17/2012
Sushi Domain Containing 2 (SUSD2): a plasma membrane protein that increases immune evasion in breast tumorigenesis Cancer Research
12/17/2012
CLIC3 is associated with invasive behaviour and poorer prognosis in estrogen receptor-negative breast cancer. Cancer Research
12/17/2012
Metastatic xenograft models of human estrogen receptor negative breast cancer primary cultures are driven by the recruitment of myeloid-derived suppressor cells Cancer Research
12/17/2012
Biological characterization of tumor-associated leukocytes in positive and negative lymph node breast cancer patients Cancer Research
12/17/2012
Targeting breast cancer metastasis through disruption of novel PELP1-G9a complex Cancer Research
12/17/2012
Targeting integrin signaling suppresses invasive recurrence in a three-dimensional model of radiation treated ductal carcinoma in situ Cancer Research
12/17/2012
Prognostic relevance of Claudin-2 expression in metastatic breast cancer Cancer Research
12/17/2012
A novel mutation in the tyrosine kinase domain of ErbB2: molecular and proteomic investigation of its role in breast cancer invasion Cancer Research
12/17/2012
Podocalyxin is a key regulator of breast cancer progression and metastasis. Cancer Research
12/17/2012
Expression of Quiescin Sulfhydryl Oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer. Cancer Research
12/17/2012
A requirement for neural precursor cell-expressed developmentally downregulated gene 9 during the initiation of mammary tumorigenesis in MMTV-neu mice Cancer Research
12/17/2012
Epithelial-to-epithelial transition precedes collective breast cancer invasion Cancer Research
12/17/2012
EZH2 Expands Breast Stem Cells via NOTCH Signaling, Acting to Accelerate Breast Cancer Initiation Cancer Research
12/17/2012
mTORC1 and Rictor expression in human breast cancer: correlations with clinicopathological parameters and disease outcome Cancer Research
12/17/2012
Evidence for anti-apoptosis function of GNB1 in human breast cancer Cancer Research
12/17/2012
The mRNA Expression of DAP1 in Human Breast Cancer: Correlation with Clinicopathological Parameters Cancer Research
12/17/2012
Role of the Rb and p53 Tumor Suppressor Pathways in Mammary Tumorigenesis Cancer Research
12/17/2012
KSR1 is involved in functional interaction between p53 and BRCA1 and is an independent predictor of overall survival in breast cancer Cancer Research
12/17/2012
Knocking down Suppressor of Cytokine Signaling 7 in breast cancer: The role in Insulin-like Growth Factor - I/Phospholipase C{gamma}-1 signaling Cancer Research
12/17/2012
Loss of Notch4 reduces mammary tumorigenesis by MYC and activated KRAS Cancer Research
12/17/2012
milk deposition in women's mammary duct has been a potential risk factor of breast tumor Cancer Research
12/17/2012
What is the actual impact of micrometastases in sentinel lymph nodes in regards to global survival and disease free survival Cancer Research
12/17/2012
Novel diagnostic procedure of metastasis to the sentinel lymph node of breast cancer using a semi-dry dot-blot method Cancer Research
12/17/2012
Sentinel lymph node biopsy in breast cancer: The approach in day surgery under local anaesthesia for quality-of-life and significant cost reduction Cancer Research
12/17/2012
Which combinations are helpful to predict axillary lymph node metastasis in T1 breast cancer with ultrasonography and contrast-enhanced MRI and contrast-enhanced 18F-FDG PET-CT? Cancer Research
12/17/2012
Increased Diagnostic Performance of Sentinel Lymph Node Biopsy Combined with Radiologic-pathologic Factors After Neoadjuvant Chemotherapy in Breast Cancer Patients with Cytologically Proven Node Metastasis at Diagnosis Cancer Research
12/17/2012
The utility of axillary ultrasound and sentinel lymph node biopsy in the management of metaplastic breast carcinoma Cancer Research
12/17/2012
Sentinel Lymph Node detection after previous breast tumour surgical resection: identification rate and false negative rate through a prospective multi institutional study. Cancer Research
12/17/2012
Clinicopathlogic Analysis of Invasive Breast Carcinoma with Micropapillary Component Cancer Research
12/17/2012
Prediction of axillary lymph node status in male breast carcinoma Cancer Research
12/17/2012
The results of 55 consecutive cases of intra-operative sentinel node analysis using real time polymerase chain reaction detection of cytokeratin 19 and mammoglobin expression (Metasin) to direct immediate axillary clearance. Cancer Research
12/17/2012
The impact of triple negativity on lymph node positivity in breast cancer. Cancer Research
12/17/2012
Intraoperatively-palpable "non-sentinel" nodes: should they be removed? Cancer Research
12/17/2012
Accuracy of sentinel lymph node in determining the requirement for second axillary surgeries in early breast cancer with retrospective application of the Z0011 criteria. Cancer Research
12/17/2012
Effects of axillary lymph node dissection on survival of patients with sentinel lymph node metastasis of breast cancer in the Surveillance, Epidemiology and End Results (SEER) database using a propensity score matching analysis Cancer Research
12/17/2012
Patterns of definitive axillary management in the era prior to reporting ACOSOG Z0011: comparison between NCCN Centers and hospitals in Michigan Cancer Research
12/17/2012
The Performance of the One Step Nucleic acid Amplification (OSNA) Assay in Breast Cancer Patients with Receiving Preoperative Systemic Therapy Cancer Research
12/17/2012
A Nomogram for predicting two or less axillary lymph node involvement for breast cancer Cancer Research
12/17/2012
The Institut Curie Nomogram including HER2 status predicts additional axillary metastasis in breast cancer patients with a positive sentinel node biopsy: a multicentric validation. Cancer Research
12/17/2012
Evaluation of the stage IB designation of the 7th edition of the AJCC staging system: Biologic factors are more important Cancer Research
12/17/2012
Tc 99m Tilmanocept and Sulfur Colloid Injection: A comparison of preoperative imaging and intraoperative lymphatic mapping of breast cancer patients - Localization rate and degree of localization Cancer Research
12/17/2012
Comparison of sentinel lymph node biopsy guided by the multi-modal method of indocyanine green fluorescence, radioisotope and blue dye versus the radioisotope in breast cancer; A randomized phase II trial Cancer Research
12/17/2012
Axillary Reverse Mapping: A Prospective Study on Feasibility, Oncologic Safety, and Lymphedema Prevention. Cancer Research
12/17/2012
Fluorescence mapping with indocyanine green for sentinel lymph node detection in early breast cancer - results of the ICG-10 study Cancer Research
12/17/2012
Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for hormone receptors positive metastatic breast cancer patients: the STIC CTC METABREAST trial Cancer Research
12/17/2012
Use of early CIRculating tumor CElls count changes to guide the use of chemotherapy in advanced metastatic breast cancer patients: the CirCe01 randomized trial Cancer Research
12/17/2012
InVite: an observational pilot study evaluating the feasibility of genome-wide association studies using self-reported data from patients with metastatic breast cancer treated with bevacizumab Cancer Research